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  Summary  
 
Summary 
The opportunistic bacterium Legionella pneumophila causes a severe pneumonia termed 
„Legionnaires disease” and employs a conserved mechanism to replicate within a specific vacuole 
in macrophages or protozoa such as the social soil amoeba Dictyostelium discoideum. 
L. pneumophila interacts with host cells via the Icm/Dot type IV secretion system (T4SS), which 
translocates approximately 300 different effector proteins.  
In the first part of this thesis, the effects of L. pneumophila on migration and chemotaxis of 
amoebae, macrophages or neutrophils were assessed. Using different migration assays, a dose- 
and T4SS-dependent inhibition of D. discoideum migration towards folic acid was observed as 
well as the abrogation of starvation-induced aggregation of the social amoebae. Similarly, 
L. pneumophila impaired migration of murine macrophages and neutrophils towards the 
cytokines CCL5 and TNFα or the peptide fMLP, respectively. L. pneumophila lacking LegG1, a 
T4SS-translocated effector and activator of the small GTPase Ran, caused a hyper-inhibition of 
D. discoideum, macrophage and neutrophil migration. The phenotype was reverted by providing 
LegG1 on a plasmid to a similar extent as observed for mutant bacteria lacking a functional 
Icm/Dot T4SS. Likewise, LegG1 promoted random migration of infected macrophages and 
epithelial cells in a Ran-dependent manner. Single-cell tracking and real-time analysis of 
L. pneumophila-infected phagocytes revealed that the velocity and directionality of the cells were 
decreased. Moreover, the cell motility as well as microtubule dynamics were impaired. Taken 
together, these findings suggest that Ran activation by the L. pneumophila effector LegG1 and 
subsequent microtubule polymerization are implicated in Icm/Dot-dependent inhibition of 
phagocyte migration. 
Small molecule signaling promotes the communication between bacteria as well as among 
bacteria and eukaryotes. L. pneumophila employs the autoinducer LAI-1 (3-hydroxypentadecane-
4-one) for cell-cell communication. LAI-1 is produced and detected by the Lqs (Legionella quorum 
sensing) system, which regulates a variety of processes including pathogen-host cell interactions 
and natural competence for DNA uptake. In the second part of this thesis, the role of LAI-1 in 
inter-kingdom signaling was analyzed.  
 
  Summary  
 
Using migration assays, it was shown that L. pneumophila lacking the autoinducer synthase LqsA 
no longer impeded the migration of infected cells and synthetic LAI-1 dose-dependently inhibited 
cell migration, without affecting uptake, cytotoxicity or intracellular bacterial replication. The 
forward migration index but not the velocity of LAI-1-treated cells was reduced. Moreover, the 
microtubule and actin cytoskeleton appeared strongly destabilized. LAI-1-dependent inhibition of 
cell migration involved the scaffold protein IQGAP1, the small GTPases RhoA and Cdc42 as well as 
the Cdc42-specific guanine nucleotide exchange factor ARHGEF9. Upon treatment with LAI-1, 
Cdc42 was inactivated and IQGAP1 redistributed to the cell cortex independently of Cdc42. Thus, 
under these conditions, IQGAP1 functions upstream of Cdc42. Furthermore, LAI-1 reversed the 
inhibition of cell migration by L. pneumophila in a Cdc42-dependent manner, suggesting that the 
compound and the bacteria reciprocally target the same signaling pathway. Collectively, the 
results indicated that the L. pneumophila quorum sensing compound LAI-1 inhibits chemotactic 
and random migration of eukaryotic cells through a signaling pathway comprising IQGAP1, Cdc42 
and ARHGEF9. 
 
In summary, the results described in this thesis led to new insights regarding the effect of 
L. pneumophila on host cell migration and identified the effector protein LegG1 as well as the 
signaling molecule LAI-1 as modulators of chemotaxis processes of phagocytes. 
 
 
 
 
 
 
 
  Zusammenfassung 
 
Zusammenfassung 
Das opportunistische Bakterium Legionella pneumophila infiziert Umweltamöben und 
verursacht eine schwere Lungenentzündung, die „Legionärskrankheit“ indem es alveolare 
Makrophagen infiziert. Die intrazelluläre Replikation erfolgt in einer Vakuole mittels des Icm/Dot 
Typ IV Sekretionssystems (T4SS), durch welches bis zu 300 verschiedene „Effektor“-Proteine in 
die Wirtszelle eingeschleust werden.  
Im ersten Teil dieser Arbeit werden die Effekte einer L. pneumophila Infektion auf die Migration 
und Chemotaxis von Amöben, Makrophagen und Neutrophilen analysiert. Mittels verschiedener 
Migrationsversuche wurde eine Dosis- und T4SS-abhängige Chemotaxis Inhibition von 
D. discoideum zu Folsäure festgestellt sowie auch der Aushungerungs-induzierten Aggregation. 
Ebenso wurde eine Hemmung der Chemotaxis von Makrophagen zu CCL5 oder TNF und von 
Neutrophilen zu fMLP ermittelt. Eine Infektion mit L. pneumophila Mutanten-Stämmen mit 
fehlendem LegG1 Effektor führte zu einer verstärkten Inhibition der Migration von D. discoideum, 
Makrophagen und Neutrophilen. Dieser Phänotyp konnte revertiert werden, indem LegG1 durch 
ein Plasmid produziert wurde. Das Migrationsverhalten war vergleichbar mit Zellen, die mit einer 
Mutante, die kein funktionelles T4SS mehr besitzt, infiziert wurden. Des Weiteren wurde 
nachgewiesen dass LegG1 die nicht-gerichtete Migration von Epithelzellen in Abhängigkeit der 
Ran GTPase fördert. Jedoch haben Einzelzellanalysen gezeigt, dass die Geschwindigkeit und die 
gerichtete Migration von infizierten Phagozyten, durch Beeinträchtigung des Microtubuli-
Netzwerkes, reduziert wurden. Diese Experimente liessen den Schluss zu, dass LegG1, welches 
die GTPase Ran aktiviert, als Antagonist der Icm/Dot-abhängigen Inhibition der 
Zellmigration wirkt.  
L. pneumophila ist in der Lage Zell-Zell-Kommunikation durchzuführen mittels des α-
Hydroxyketon (AHK) Autoinduktormoleküls 3-Hydroxypentadekan-4-on (LAI-1: Legionella 
Autoinducer-1). LAI-1 wird produziert und erkannt durch das Lqs (Legionella quorum sensing) 
System, welches wichtige Prozesse reguliert wie Pathogen-Wirtszell-Interaktionen und die 
natürliche Kompetenz für DNA-Aufnahme. Im zweiten Teil dieser Arbeit wurden die 
Signaltransduktion und Effekte von LAI-1 auf Wirtszellmigration untersucht.  
  Zusammenfassung 
 
Anhand verschiedener Migrationsversuche wurde gezeigt, dass eine Infektion mit einem 
L. pneumophila Stamm, welcher die Autoinduktorsynthase LqsA nicht mehr produziert, keine 
Inhibition der Migration mehr verursacht.  
Des Weiteren wurde eine Dosis-abhängige Hemmung der Zellmotilität durch LAI-1 entdeckt, die 
keine Auswirkung auf Zytotoxizität und bakterielle Aufnahme oder intrazelluläre Replikation 
hatte. Sowohl die gerichtete Zellmigration als auch das Aktin und Mikrotubuli Netzwerk wurden 
durch die LAI-1 Zugabe beeinträchtigt. Die LAI-1-abhängige Inhibition der Motilität erfolgt über 
das Gerüstprotein IQGAP1, ebenso wie über die kleinen GTPasen RhoA und Cdc42 zusammen mit 
dem spezifischen Aktivator ARHGEF9. Nach LAI-1 Behandlung wurde Cdc42 inaktiviert und 
IQGAP1 relokalisierte in der Zelle vom Zytoplasma zum Zellkortex. Unter diesen Bedingungen 
wirkte IQGAP1 hierarschich oberhalb von Cdc42 in der Signalkaskade. Zudem wurde gezeigt, dass 
LAI-1 die von L. pneumophila verursachte Inhibition der Zellmigration in Abhängigkeit von Cdc42 
revertiert und somit den selben Signalübertragungsweg reziprok beeinflusste. Zusammengefasst 
zeigen diese Daten dass LAI-1 die Migration von Wirtszellen inhibiert, indem das Molekül eine 
Signalkaskade aktiviert, welche IQGAP1, Cdc42 und ARHGEF9 beinhaltet. 
 
Die im Rahmen dieser Arbeit präsentierten Ergebnisse liefern neue Erkenntnisse bezüglich des 
Einflusses von L. pneumophila Effektor Proteinen und Signalmolekülen auf die Zellmigration. 
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I. Introduction 
A.   Pathogenesis of Legionella pneumophila 
1. From environmental sources to disease 
In the summer of 1976, over 200 persons attending the 58th American Legion´s 
convention in Philadelphia began to fall ill presenting mysterious symptoms ranging from fever to 
coughing over breathing difficulties 1, 2. Serum analysis and infected lung extracts allowed the 
identification of the Gram-negative bacterium Legionella pneumophila to be responsible for this 
explosive outbreak of pneumonia 3. Besides causing pneumonia, an infection with L. pneumophila 
does not have to be life-threatening and can also cause influenza-like symptoms termed Pontiac 
fever. The family Legionellaceae comprises over 50 species with several serogroups; yet over 90% 
of human infections are caused by L. pneumophila 4, 5. The exception is Australia and New 
Zealand, where Legionella longbeachae, found also associated with plants and soil, is the most 
common causative agent 6.  
The aerobic bacterium can survive and replicate in biofilms as well as in free living protozoa 
including Dictyostelium discoideum, Acanthamoeba castellanii and Hartmanella vermiformis as 
well as in man-made aquatic systems, such as cooling towers, whirlpools and showers 7, 8. To 
date, no transmission between humans has been reported. Evolutionary adaptation, based on 
horizontal gene transfer, allows L. pneumophila to persist in a variety of extra- and intracellular 
niches 9, 10. The environment inside protozoa or biofilms protect the bacteria from physical and 
chemical threats, such as antibiotics, radiation, high temperatures, biocides and detergents 11. 
The temperature range of replication is between 25 – 42 °C, where 35 °C is the optimal growth 
condition 12. Upon inhalation of contaminated aerosols, the bacterium employs a conserved 
mechanism to replicate within alveolar macrophages of the innate immune system. 
L. pneumophila possesses a biphasic life cycle and alternates between a replicative, non virulent 
and a transmissive, virulent phase (Figure 1) 13.  
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The opportunistic pathogen uses a type IV secretion system (T4SS; section A.2) to secrete a 
plethora of effector proteins, which guarantee intracellular replication by subverting host 
signaling pathways (section A.3).  
 
Figure 1. Environmental cycle of Legionella spp. and human infection.  
Legionella spp. survive in the environment as planktonic bacteria, colonize biofilms and multiply in free-
living protozoa. After release from their replicative niches, transmission happens via inhalation of bacteria-
containing aerosols. Highly virulent bacteria infect and replicate in alveolar macrophages, thus triggering 
inflammation and the severe pneumonia called “Legionnaires’ disease”. 
 
2. The Icm/Dot type IV secretion system 
T4SS are employed by many pathogenic bacteria to govern virulence, DNA transfer 14, 
conjugation 15 and transport of effector proteins 16, 17. Bacterial uptake and growth as well as the 
subversion of host cell processes are promoted by the translocation of so-called effector 
proteins. Numerous proteins have been described to interfere with cellular pathways, such as 
small GTPase activation 18, retrograde trafficking 19 or ubiquitinylation and apoptotis 20. The key 
virulence component of L. pneumophila is the Icm/Dot (intracellular multiplication/defective for 
organelle trafficking) system exporting over 300 different effector proteins into the host cell 21, 22.  
Those proteins are able to interfere with numerous pathways by targeting small GTPases, 
microtubule-dependent cascades as well as phosphoinositide (PI) metabolism.  
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The T4SS is composed of two large subcomplexes including 27 proteins. Five cytoplasmic and 17 
inner membrane associated proteins have been identified as well as one periplasmic and four 
outer membrane proteins (Figure 2). The first complex consists of DotC, DotD, DotF (IcmG), DotG 
(IcmE) and DotH (IcmK) and connects the inner and outer membrane of L. pneumophila. DotF 
and DotG represent inner membrane proteins whereas DotC and DotD are two outer membrane 
lipoproteins interacting with DotH 17, 23. The second subcomplex, localized at the inner 
membrane, consists of five proteins: DotL (IcmO), DotM (IcmP), DotN (IcmJ), IcmS and IcmW 24.  
DotL regulates the secretion apparatus and creates a link between the subtrates and the 
transport machinery. IcmS and IcmW are adaptor proteins controlling the selection of secreted 
proteins 25, 26. Those chaperone-like proteins are required for the export of SdeA, SidA, SidB, SidD, 
SidF, SidG and SidH 23. Furthermore, three supplementary cytoplasmic proteins, DotB, IcmQ and 
IcmR, were described to be involved in the assembly of the T4SS and formation of pores in the 
cell membrane. In addition to the T4SS, L. pneumophila harbors four other secretion systems 27. 
The Lss T1SS consists of three proteins; the ABC (ATP binding cassette) transporter, a membrane 
fusion protein and an outer membrane protein 28. No substrates have been identified for the 
T1SS yet. The type II Lsp system consists of a membrane spanning apparatus and translocates 
several enzymes such as phosphatases, lipases or chitinases 27. Together with the T4SS, the T2SS 
represents the most important system required for infection and modulation of host cell immune 
responses. The Lvh T4SS contains 11 genes homologous to other T4SS and is implicated in 
conjugation and DNA transfer 27, 29. Last, a putative T5SS was identified in the L. pneumophila 
Paris strain 27, 30. Composition or substrates of this secretion system have not been identified yet. 
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Figure 2. The Icm/Dot T4SS. 
The T4SS is composed of 27 proteins divided in two main complexes allowing the transport of bacterial 
proteins and DNA. The core subcomplex includes DotF, DotG, DotH, DotC and Dot D (green). The 
second complex is composed of the coupling protein DotL bridging the effector proteins with the transport 
apparatus, DotM, DotN, IcmS and IcmW (grey). IcmX was identified as a periplasmic protein and DotB as 
a hexameric ATPase regulating the assembly of the T4SS and the selection of effector proteins. Model 
adapted from 
25, 26
. 
 
3. Host cell infection 
L. pneumophila enters the host cell through actin-dependent phagocytosis, a process in 
which the T4SS plays an essential role (Figure 3) 31, 32. Adhesion and entry are the primary steps 
of the infection conducted by several effectors including SdeA (LaiA), LadC, EnhC and                
LpnE 33, 34, 35, 36. Immediately after internalization, the bacterium resides in a membrane-bound 
compartment termed the Legionella-containing vacuole (LCV) and avoids fusion with lysosomes 
in an Icm/Dot T4SS-dependent manner 37. Numerous Icm/Dot substrates of L. pneumophila are 
involved in this important step. For example, SidK inhibits phagosomal acidification required for 
bacterial lysis by targeting VatA, the catalytic subunit of the vacuolar H+-ATPase, which is 
necessary to establish an acidic environment 38. Furthermore, the effector LegC3 was proposed 
to counteract membrane fusion events thus protecting the bacteria 39, 40.  
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In addition, vacuole protein sorting (VPS) inhibitors such as VipA, VipD and VipF are able to block 
lysosomal trafficking through multiple mechanisms 41. Moreover, bacterial lipopolysaccharide 
(LPS) molecules circumvent lysosomal killing in an effector-independent way 42. Shorlty after LCV 
formation, many docking events take place leading to the recruitment of mitochondria, smooth 
vesicles from the endoplasmic reticulum (ER) and later ribosomes 43, 44.  
Establishement of LCVs is coordinated by the use of PIs, phosphorylated derivates of 
phosphatidylinositol (PtdIns) and small GTPases 45, 46. Proteome analysis revealed that over 560 
host proteins decorate the LCV including small GTPases of the secretory (Arf1, Rab1, Rab8) or 
endosomal (Rab7, Rab14) vesicle trafficking cascades 47. 
PtdIns(3)P and PtdIns(4)P represent relevant PIs involved in endosomal and secretory trafficking. 
The effector protein SidC is localized on the LCV and was described to promote LCV/ER fusion 
and bind to PtdIns(4)P via its N-terminal and C-terminal part, respectively 48, 49, 50. LidA promotes 
the recruitment of early secretory vesicles to the LCV  and interacts with Rab1, Rab6 and Rab8 as 
well as with PtdIns(3)P and PtdIns(4)P 51, 52. Moreover, the effector protein LpnE binds PtdIns(3)P 
and host enzymes like human OCRL1 as well as the D. discoideum homologue Dd5P4, which is 
involved in PI metabolism 52, 53, 54. Notably, the phosphoinositide 3-kinase (PI3K) also plays a role 
in bacterial uptake and vesicle trafficking 48. The Icm/Dot substrate SidM also interacts with 
PtdIns(4)P, exhibits Rab1 guanine nucleotide exchange factor (GEF) activity and catalyses the 
AMPylation of Rab1, Rab8 and Rab14 46, 52, 55. This effector creates a link between the exploitation 
of small GTPases and PI lipids. Lastly, RalF was identified as an Icm/Dot T4SS effector protein, 
which is not binding PIs but is responsible for the recruitment and activation of the ADP-
ribosylation factor 1 (Arf1), thus influencing membrane transport and organelle structure 56, 57.  
After LCV formation is completed, L. pneumophila switches from a transmissive into a replicative 
phase allowing proliferation of the bacteria. The substrate AnkB was described to be essential for 
intravacuolar replication by subverting the polyubiquinylation machinery. The proteolytic 
removal of effectors from the LCV favors intracellular propagation 58. Also, the effector RavZ 
inhibits autophagy during L. pneumophila infection by targeting autophagy related proteins 
(Atg8), thus allowing intracellular replication 59.  
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For termination of the replicative cycle, the bacteria might be released by non-lytic egress via the 
effectors LepA and LepB or pore formation 60, 61. Subsequently, L. pneumophila can start a new 
infection cycle and persist in the environment by colonizing biofilms or reinfect host cells.  
 
 
Figure 3. Infection cycle of L. pneumophila.  
The intracellular transmissive and replication phases of L. pneumophila can be divided in seven main 
steps: 1. Adhesion and entry into the host cell via phagocytosis; 2. Formation of the LCV in an Icm/Dot 
T4SS-dependent manner and recruitement of vesicles from the ER as well as mitochondria; 3. Evasion 
from the lysosomal trafficking; 4. Fusion of surrounding ER vesicles with the LCV; 5. The compartment 
becomes a rough-ER-like vacuole and 6. allows bacterial replication; 7. L. pneumophila is released and 
can reinfect new host cells or be transmitted to other environmental niches. Relevant Icm/Dot-translocated 
effectors involved in the different steps are indicated in black. Model adapted from 
25
. 
Abbreviations: ER: endoplasmic reticulum; GA: Golgi apparatus; LCV: Legionella-containing vacuole; 
LYS: lysosome; M: mitochondria; R: ribosomes; T4SS: type IV secretion system. 
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B.   Effect of L. pneumophila on microtubule dynamics and cell migration  
1. Microtubule polymerization and function in eukaryotic cell processes 
a. Microtubule organization 
The cytoskeleton is composed of microtubules, microfilaments and intermediate 
filaments. Microtubule dynamics are essential for various vital cell processes including cell 
adhesion, protrusion formation, mitosis and cell migration. Microtubules, found in all dividing 
eukaryotic cells, are long cylindrical polymers formed of  and tubulin monomers. They are 
arranged into protofilaments in a head-to-tail fashion which bind laterally to create a hollow 
tube. Two ends are discernable; a plus-end where -tubulin is exposed and faster assembled and 
a minus-end characterized by the exposure of slowly assembled -tubulin 62. The centrosome is 
the main microtubule organization center (MTOC) responsible for the assembly of tubulin into 
microtubules. Their intrinsic dynamic behaviour is regulated at the plus-end by microtubule 
associated proteins (MAPs), influencing thereby multiple steps in cell migration, numerous 
signaling pathways and interactions with organelles or other cytoskeletal components. 
Furthermore, microtubule-associated motor proteins like kinesin and dynein as well as transport 
vesicles mediate the function of microtubules. The regulation of microtubule dynamics also 
implicates a transition between polymerization (growth) and depolymerization (shrinkage). A 
„microtubule catastrophe” reflects an interruption in growth, caused by a sudden loss of 
protection, possibly age- or length-dependent 63. The switch depends on the presence of a GTP-
cap at the end of the microtubule. Incorporation of a GTP-tubulin allows polymerization, whereas 
one of a GDP-tubulin, triggered through GTP hydrolysis, more likely promotes depolymerization 
of the microtubule 64. Numerous different rescue events can be initialized through various rescue 
sites, e.g., mediated by GTP-islands hidden in the lattice structure of the microtubule 65.  
 
b. Role in mitosis 
Mitosis corresponds to the segregation of chromosomes into two daughter cells. This 
process happens during each cell cycle and is dependent on the formation of a mitotic apparatus. 
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The separation requires a proper positioning of the mitotic spindle composed of microtubules, 
motors and associated proteins. Plus-ends of microtubules attach to chromosomes through a 
protein structure localized on chromatin centromeres, called kinetochores. There are three 
groups of spindle microtubules: kinetochores fibers with their plus-ends attached to 
chromosomes, interpolar microtubules arising from one spindle pole to the other and astral 
microtubules pointing to the cortex via their plus-end 66. Microtubule dynamics (growth and 
shrinkage) allow a lateral and end-on cell attachment and transport of kinetochores to the 
spindle pole. This happens on both sides of the cell and is termed bi-orientation. Microtubule 
forces permit the chromosomal alignment of the spindle to the center allowing chromatid 
separation. This is guided by the recruitment of plus-ending tracking proteins termed TIPs 67. The 
microtubule-dependent cell division is essential for homeostasis and tissue development.  
 
c. Implication in cell adhesion 
The capacity of cells to interact with the underlying extracellular matrix (ECM) at so called 
„focal adhesions” (FA) sites generates the required force for directed cell migration. FA, formed 
at the leading edge of a cell, are targeted by microtubules. They are responsible for the delivery 
of receptors involved in cell adhesion like integrins 68. These transmembrane proteins couple the 
ECM to the actin network and recruit FA components to modulate microtubules and the activity 
of RhoGTPases. In return, microtubule dynamics are able to influence FA by controlling their 
disassembly and thus creating mechanical forces 69. Interplay between adhesion sites, force 
generation, contractility and cytoskeletal components are vital for correct directed cell motility.  
 
d. Role in cell migration 
Cell migration is a fundamental multistep process present in single cells as well as in 
multicellular organisms and describes random and directed movement through the body. It is 
essential in immune responses, cancer, wound healing and tissue development/renewal 62. 
Directed cell migration can be induced by surface-bound stimuli, a gradient of soluble 
chemoattractants or by the presence of intracellular signals.  
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Eukaryotic immune cells use chemotaxis to move from the blood to site of infections as well as 
between the vascular and lymphatic system. Upon stimulation of membrane receptors by 
chemoattractive coumpounds such as pro-inflammatory cytokines or bacterial components (LPS, 
flagellin), the cell polarizes by forming a distinct front and rear side, dependent on the creation of 
a protrusion at the leading edge, positioning of the nucleus and reorientation of the MTOC 70, 71. 
In response to such signals, an actin-dependent extension of the cell membrane (protrusion) is 
formed at the cell front (lamellipodium or filopodium) and allows the cell to move forward. 
Furthermore, in order to create a cell protrusion, most cells rely on actin polymerization and 
microtubule dynamics through their signaling properties and crosslinking with intermediate 
filaments. Microtubules can act directly or indirectly by delivering small RhoGTPases like the cell 
division control protein (Cdc42) and the Ras-related-activating protein (Rac1) together with their 
regulators to the cell membrane and influencing their activities 72.  Indeed, the activity of Cdc42 
in association with an intracellular PI gradient regulate the polarization pathway during motility.  
A rise of phosphatidylinositol-3,4,5-triphosphate (PIP3) is generated by the activation of PI3K at 
the leading edge and the phosphatase and tensin homolog (PTEN) at the back 73. A polarity 
center is formed at the plasma membrane between the master regulator Cdc42-GTP and the 
partitioning defective (Par) complex composed of Par6/atypical protein kinase C (aPKC)/Par3 74. 
Additionally, the formation of a front-rear axis is promoted by the Cdc42-dependent regulation of 
microtubule plus end tracking protein (CTIPs) like the cytoplasmic linker protein of 170 kDa (CLIP-
170). The interaction between Rac1/Cdc42 with CLIP-170 and the Ras GTPase-activating-like 
protein (IQGAP1, section A.2.a.) at the leading edge contributes to a polarized microtubule 
array 75. Cell adhesion, contraction and retraction represent key steps of the migration cycle. As 
described above, microtubules control dynamics of focal adhesion complexes and integrin-
mediated adhesion. In concert with cell retraction regulated by the small GTPase Ras homolog 
gene family member A (RhoA) located at the rear edge and retraction of the cell body, the 
required force for pulling the rear of the cell forward is generated.  
D. discoideum amoebae represent a powerful tool in the analysis of directed migration. Indeed, 
the social amoebae produce cyclic adenosine 3´,5´-monophosphate (cAMP) and aggregate 
chemotactically under starvation conditions 76, 77.  
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In order to survive, fruiting bodies and spores can then be formed. Genes encoding components 
necessary for the signaling cascade are up-regulated such as cAMP receptors. Four have been 
identified and termed cAR1-4. cAR1 and cAR3 are involved in early developmental states whereas 
cAR2 and cAR4 are important during late developmental phases 78. As described for eukaryotic 
cells, the signaling cascade comprises a stimulation of membrane receptors, the production of 
PIP3 by PI3K as well as the activation of Ras and small GTPases 79, 80, 81.  This leads to the 
formation of pseudopods and subsequent directed migration. During a normal life cycle, 
D. discoideum amoebae sense folic acid gradients allowing their movement in search of 
bacteria 82. As mentioned, actin polarization is essential and causes through polymerization 
pseudopod formation at the leading edge and via depolymerization retraction at the trailing 
edge 78.  
In summary (Figure 4), the bidirectional organization of the microtubule network ranging from 
the leading edge to the rear edge and the activity of small GTPases coordinate cell protrusion, 
polarization, adhesion, contraction and retraction necessary for directed cell migration 62. 
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Figure 4. Schematic representation of cell migration.  
The migration cycle can be divided into four major steps: protrusion at the leading edge, cell adhesion and 
contraction to generate the required forces and retraction at the rear edge. Microtubule dynamics and the 
actin cytoskeleton in concert with RhoGTPases are fundamental components of each phase. 
Abbreviations: aPKC: atypical protein kinase C; Cdc42: cell division control protein 42; CLIP170: 
cytoplasmic linker protein 170; FA: focal adhesion; GA: Golgi apparatus; GAP: GTPase activating protein; 
GEF: guanine nucleotide exchange factor; GSK3: glycogen synthase kinase 3; IQGAP1: Ras GTPase-
activating protein; MLC: myosin light chain; MTOC: microtubule organizing center; Par3/6: partitioning 
defective 3/6 homolog; Rac1: Ras-related C3 botulinum toxin substrate 1; RhoA: Ras homolog gene 
family member A; ROCK: Rho-associated protein kinase. 
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2. The bacterial effector LegG1 stabilizes microtubule polymerization 
a. The Ran cycle  
Recent proteomics studies of purified LCVs identified over 560 host proteins including a 
plethora of small GTPases. Among those, the Ras-related nuclear protein (Ran) and its effector 
RanBP1 were found to be LCV components. Ran is a member of the Ras superfamily of small 
GTPases and regulates many essential functions like nucleo-cytoplasmic transport, mitosis and 
regulation of microtubule dynamics. Like other GTPases, Ran exists in an activated GTP-bound 
and in an inactivated GDP-bound form.  
Activation happens in the nucleus via the Ran guanine nucleotide exchange factor (RanGEF) 
termed RCC1 (regulator of chromosome condensation 1). The cytoplasmic Ran GTPase activating 
protein (RanGAP1), together with RanBP1, orchestrates the inactivation of Ran 83. As mentioned, 
Ran plays a crucial role in nuclear transport during interphase. Over 20 nuclear transport 
receptors (NTRs) have been identified, among them importin-α, importin-β and exportin, 
controlled by RanGTP, which are the main factors regulating cargo delivery. A gradient of RanGTP 
and RanGDP is maintained at high levels in the nucleus and the cytosol, respectively, and is the 
driving mechanism for nuclear transport. Cargo proteins leaving the nucleus are associated with 
exportins and those imported are combined with importins via their nuclear localization signal 
(NLS) and nuclear export signal (NES) tags, respectively. In the nucleus, RanGTP is maintained at a 
high concentration by RCC1 and dissociated from the formed nuclear import signal 84, 85. 
Furthermore, RanGTP forms in the nucleus a complex with proteins exhibiting leucine-rich 
nuclear export signals. After translocation of the complex through the nuclear pore, RanGTP is 
released from its cargo proteins in the cytosol through GTP hydrolysis converting Ran into its 
inactivated RanGDP form. In the cytosol, the gradient is preserved by RanGAP in combination 
with RanBP1 and RanBP2 86.  
Besides its main role in nuclear transport, RanGTP is essential for the regulation of the mitotic 
spindle assembly in dividing cells. Early findings using fluorescence energy transfer (FRET) in 
Xenopus laevis eggs revealed RCC1 to possess high affinity for chromatin and to maintain a 
gradient of RanGTP around the mitotic chromosomes.  
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Nuclear export and import signals dissociated from RanGTP function as SAFs (spindle assembly 
factors) and allow the recruitment of proteins to specific sites of the spindle apparatus during 
mitosis 87. Additionally, the high RanGTP concentration leads to microtubule nucleation close to 
chromatin whereas low concentrations located further away stabilizes the centrosomal 
microtubules 88. These data indicate that Ran activation in mitotic cells controls the assembly of 
microtubule spindles and the nucleo-cytoplasmic transport.  
 
b. LegG1, a novel RanGTPase activator 
Recently, the Icm/Dot-translocated effector Legionella eukaryotic gene 1 (LegG1) was 
identified as the first prokaryotic Ran activator (Figure 5). The L. pneumophila protein LegG1 
(alias PieG, Lpg1976) is encoded in the plasticity island of effectors (Pie) gene cluster and 
possesses an amino acid homology to the RanGEF RCC1 89, 90. The legG1 gene is conserved among 
all L. pneumophila strains sequenced to date. The C-terminal CAAX tetrapeptide motif of LegG1 is 
lipidated by the host prenylation machinery to accomodate the targeting of bacterial protein to 
host membranes 91. Proteomics data and fluorescence microscopy show that Ran, its effector 
RanBP1 and LegG1 localize to LCVs in an Icm/Dot-dependent manner. Using LCVs harboring 
ΔlegG1 mutant bacteria, LegG1 was identified to be able to catalyze the activation of Ran and to 
promote the accumulation of RanBP1 on LCVs. Moreover, LegG1 is a virulence factor which 
promotes intracellular replication of L. pneumophila and LCV motility 18, 92. As Ran controls 
microtubule assembly and microtubule-dependent trafficking, LegG1 influences microtubule 
dynamics. Different approaches including siRNA treatment to knock-out LegG1 and microbial 
microinjection of the effector protein using the Yersinia T3SS toolbox confirmed that the 
L. pneumophila effector is implicated in microtubule polymerization in amoebae and 
macrophages 18. These findings paved the way for new studies to elucidate the effect of LegG1 
on host cell migration. 
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 Figure 5. The Ran cycle.  
The small GTPase Ran switches 
between two forms: an active 
GTP-bound and an inactive GDP-
bound form. RanGEFs such as 
RCC1 mediate the conversion of 
RanGDP into RanGTP. RanGAPs 
for example RanBP1 or RanGAP1 
converse RanGTP in its inactive 
mode through GTP-hydrolysis. 
LegG1 has been identified as a 
L. pneumophila effector able to 
activate Ran. 
Abbreviations: GAP: GTPase 
activating protein; GEF: guanine 
nucleotide exchange factor. 
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C.   Pathogen-host cell interaction 
1. Quorum sensing systems in bacteria 
Research in quorum sensing (QS) started in the late 1960s and was described as a process 
allowing bacteria to perform cell-cell communication. The system is ubiquitously found in 
bacteria and frequently comprises a two-component system (TCS) using a sensor histidine kinase 
and a response regulator 93. Around 1970, the groups of Nealson and Eberhard identified the first 
density sensing mechanism in the Gram-negative marine bacterium Vibrio fischeri reviewed in 
reference 94. This led to the establishment of a basic model incorporating the production, 
detection and integration of signaling molecules termed autoinducers (AIs). A certain threshold 
concentration is required for response, which is dependent on the cell density of the bacterial 
population called the quorum. The AI concentration increases simultaneously with the growing 
bacterial population. Bacteria use QS to track changes in cell density and coordinate gene 
expression for many processes including virulence, biofilm formation, sporulation, competence 
and bioluminescence 95. QS systems can be divided into two major groups: the oligopeptide 
system employed by Gram-positive bacteria and the LuxI-LuxR system used by Gram-negative 
bacteria (Figure 6).  
 
a. Quorum sensing in Gram-positive bacteria 
            Gram-positive bacteria employ autoinducer peptides (AIPs) which can modify the 
expression of genes involved in competence, e.g., in Streptococcus pneumonia or Bacillus subtilis, 
or virulence, e.g., in Listeria monocytogenes, Enterococcus faecalis, Staphylococcus aureus or 
Bacillus cereus 96. S. aureus, present in the skin flora and responsible for pneumonia and sepsis, 
employs a QS system encoded by the agr (accessory gene regulator) operon and can be 
described as a model for Gram-positive bacteria 97. It is composed of four essential components; 
the propeptide AgrD encodes the proAIP processed to its active form by a multifunctional 
endopeptidase, AgrB. AgrC is the membrane-bound histidine kinase and binds the extracellularly 
accumulating AIP and autophosphorylates it.  
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A phosphate group is transferred from a conserved histidine of AgrC to a conserved aspartate of 
AgrA, thereby activating AgrA. The resulting activation of the promoters P2 and P3 triggers the 
up-regulation of the agr operon and promotes the expression of virulence factors 98. 
 
b. Quorum sensing in Gram-negative bacteria 
The QS circuit of the bacterium V. fischeri is responsible for the induction of lumiscence 
and produces a diffusible autoinducer molecule (N-(3-oxohexanoyl)-homoserine lactone (3-oxo-
C6-HSL)) via the LuxI-LuxR system 94. Furthermore, two additional QS systems have been 
described, the AinS-AinR and the LuxS-LuxP/Q systems producing C8-HSL and AI-2, respectively. 
However, most Gram-negative bacteria use homologues of the LuxI-LuxR QS system to perform 
cell-cell communication. This is the case for the bacterium Vibrio cholerae, the causative agent of 
the disease cholera. The main symptoms are diarrhea and dehydration triggered by the cholera 
toxin, the production of which is dependent on QS. Two autoinducer molecules are synthesized: 
(S)-3-hydroxytridecan-4-one (CAI-1) and a furanosyl borate diester (AI-2) produced by the kinases 
CqsA and LuxS, respectively 95. The signals are detected by CqsS and LuxPQ, thus triggering the 
phosphorylation of the common response regulator LuxO. Consequently, the expression of qrr1-4 
(quorum regulatory sRNAs) genes is activated, which positively regulates biofilm formation at low 
cell density in V. cholerae 99.  
During the last decade, QS has been well described in the bacterium Pseudomonas aeruginosa, 
which is an opportunistic, highly adaptable pathogen causing chronic and acute infections in 
immune-deficient humans and is found in lungs from persons suffering from cystic fibrosis. This 
bacterium harbors two LuxI-LuxR homologous QS systems and one PQS circuit which integrate 
two chemically distinct classes of signaling molecules, the N-acylhomoserine lactones (AHLs) and 
the quinolones 100. The first pathway comprises the LuxI homologue LasI which synthesizes the 
homoserine lactone 3O-C12-HSL detected by the cytoplasmic LuxR homologue LasR. The second 
pathway includes a LuxI homologue termed RhlI responsible for the production of C4-HSL 
detected by RhlR. Additionally, P. aeruginosa employs a third circuit, the Pseudomonas quinolone 
system (PQS) to control cooperative responses and biofilm formation 101.  
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This system comprises the autoinducer synthase pqsABCDH synthetizing PQS and the 
transcription regulator PqsR binding the AI molecule. The different QS molecules target genes 
including those encoding virulence factors like elastase, rhamnosyltransferase, proteases, the 
stationary phase sigma factor s and toxic lectins. Besides promoting host cell interactions and 
regulating virulence, the Vikstrom group showed that AHL molecules from P. aeruginosa 
influence epithelial cell migration in an IQGAP1-dependent manner (section C.2.c) 102. 
Furthermore, AHL-12 was described to induce neutrophil migration by altering the 
phosphorylation state of p38 (mitogen-activated protein kinase) and LSP1 (leukocyte specific 
protein 1) crucial for actin polymerization 103. The AHLs, PQS and quinolone signaling molecules 
possess immune-modulatory functions by inhibiting cytokine release and immune cell 
activation 104. Clear evidence has now been obtained that prokaryotes and eukaryotes 
communicate via signaling molecules through a process called inter-kingdom signaling.  
 
Figure 6. Representative models for QS systems in Gram-positive and -negative bacteria.  
A. In Gram-positive bacteria, an AIP molecule is synthesized, processed into its active form and 
transported out of the cell via the ABC transporter. Once the threshold concentration is reached, the 
signal is detected by a histidine sensor kinase which auto-phosphorylates and transfers the phospho-
group to the conserved aspartate of the response regulator. This leads to the transcription activation of 
various target genes.  
B. The QS circuit of the Gram-negative V. fischeri comprises two proteins, LuxI and LuxR encoded by the 
luxI and luxR genes, respectively. LuxI synthesizes the AI molecule 3-oxo-C6-HSL. At high bacterial 
density, the intra- and extracellular AI concentration increases and allows the formation of a LuxR-HSL 
complex. The transcription of the luxICDABE operon induces light production and activates through the 
binding of this complex the corresponding promoter.  
Abbreviations: ABC: ATP-binding cassette; AI: autoinducer; AIP: autoinducer peptide. 
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c. Quorum sensing in L. pneumophila 
L. pneumophila uses an endogenously synthetized AHK (alpha-hydroxyketone) 
autoinducer molecule to perform cell-cell communication during the stationary growth phase. 
The components of the L. pneumophila QS circuit are encoded by the Legionella quorum sensing 
(lqs) gene cluster (lpg2731-2734) and composed of the autoinducer synthase LqsA producing the 
AI molecule Legionella autoinducer-1 (LAI-1), the sensor kinase LqsS and the response regulator 
LqsR. Furthermore, LqsT (lpg2506) was recently described as a novel LAI-1 responsive sensor 
kinase during AHK signaling (Figure 7) 105. 
 
 
 
 
 
 
Figure 7. The L. pneumophila lqs 
gene cluster and LAI-1 signaling 
circuit.  
A. The autoinducer synthase LqsA, the 
response regulator LqsR and the 
cognate sensor kinase LqsS are 
located in the lqs gene cluster 
(lpg2731-lpg2734). The orphan sensor 
kinase lqsT is located close to the 
effector genes sdeD, sdcA and sidC.  
B. The autoinducer signaling molecule 
3-hydroxypentadecane-4-one LAI-1 is 
produced by LqsA and detected by 
LqsS and LqsT. The signal is 
transmitted through the response 
regulator LqsR. Phosphorylation 
reactions lead to the dimerization of 
LqsR. Dashed arrows represent 
hypothetical interactions.  
Abbreviations: LAI-1: Legionella 
autoinducer 1; Lqs: Legionella  quorum 
sensing. 
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LqsA shares 45% homology with CqsA and can partially complement the depletion of cqsA in 
V. cholera, thus displaying functional similarities. The autoinducer synthase LqsA exhibits a 
conserved lysine residue which binds to pyridoxal-5´-phosphate. Strains lacking lqsA are mildly 
defective for pathogen-host interactions 106. LqsS is 29% identical to CqsS and a member of the 
six transmembrane helix two component sensor histidine kinases family. Mutant strains lacking 
lqsS show impairment in salt resistance and virulence. Also, the up-regulation of a „fitness island” 
encoding metal ion transport systems and pilus components was described for ΔlqsS strain 107. 
Interestingly, it was recently observed that this phenotype can be reversed by an overexpression 
of lqsA, leading to the identification of a novel sensor kinase LqsT. The orphan lqsT gene 
(lpg2506) located near the effector genes sdeD, sdcA and sidC, is expressed from its own 
promoter and shares 31% homology to LqsS. In comparison to wild-type L. pneumophila, strains 
lacking lqsS or lqsT displayed enhanced salt resistance and alterations in uptake by phagocytes. 
Additionally, LqsS and LqsT are antagonistic sensors; indeed, 90% of genes down-regulated in 
ΔlqsT strains were up-regulated in strains lacking lqsS 105. The response regulator LqsR, also 
encoded in the lqs cluster, stimulated host-pathogen interactions, suppressed replication and is 
an element of the stationary phase regulatory network. Its production is dependent on the 
LetA/LetS two-component system and the sigma factor RpoS (38). LetA induces the expression 
of small non-coding RNAs which sequester the repressor of virulence traits CsrA. RpoS in concert 
with LetA positively acts on LqsR by inducing the transmission phenotype (virulence and motility). 
Compared to wild-type, strains lacking lqsR and/or lqsS presented a reduced sedimentation due 
to the formation of extracellular filaments 108. Furthermore, it was recently shown that 
phosphorylation signaling via LqsS and LqsT converges on LqsR. LqsS and LqsT are 
autophosphorylated and are bound by LqsR or phospho-LqsR. After phosphorylation on its 
conserved aspartate residue (D108), LqsR was able to form dimers 109. QS autoinducers regulate 
a plethora of signaling pathways including eukaryotic cell migration as described in P. aeruginosa. 
These findings led us to address the question of whether LAI-1 might affect host cell motility. 
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2. Involvment of IQGAP1 in cell migration and quorum sensing signaling 
a. The IQGAP family of proteins and interacting targets 
The IQGAP family of proteins was identified in numerous organisms ranging from yeast to 
mammals. Three IQGAPs have been isolated in humans, termed IQGAP1, IQGAP2 and IQGAP3 110. 
Described for the first time in 1994, IQGAP1 is the best-studied family member and a 
ubiquitously expressed scaffold protein. Numerous functions have been associated with IQGAP1, 
for example the regulation of the cytoskeleton, microbial infection, cell-cell contact and cell 
migration. Furthermore, changes in expression levels of IQGAP1 have been related to cancer 
progression. IQGAP1 is a multidomain protein (Figure 8) which can bind to over 90 different 
interaction partners. Binding occurs through five main domains. First, the calponin homology 
domain in the N-terminal part associates reversibly with F-actin, thus enhancing actin 
polymerization. The WW domain of IQGAP1 is involved in the mitogen-activated protein kinase 
(MAPK) cascade and oncogenic signaling in cancer by modulating epidermal growth factor 
receptor (EGFR) activation. The IQ motif targets calmodulin, a calcium-binding protein and 
reduces the interaction with other IQGAP1 targets. A Ras GTPase-activating protein related 
domain (GRD) is responsible for the modulation of the cytoskeleton by interacting with two Rho 
GTPases, Cdc42 and Rac1. Finally, the C-terminal domain termed RasGAP C-terminal (RCG) binds 
to E- and -cadherin as well as CLIP-170 a microtubule-binding protein affecting cell adhesion 
and capture of microtubules 111. IQGAP2 and IQGAP3 share 62% and 57% identity with IQGAP1, 
respectively. IQGAP2, predominantly confined to the liver, has been associated with gastric 
cancer. Similarly, IQGAP3 expression is mainly localized to the brain, lung and intestines and 
contributes to tumorgenesis by interacting with the EGFR signaling pathway, modulating target 
partners like Ras and Cdc42. Homologues of IQGAP proteins have been identified in yeast and 
amoebae 112. The fission yeast Schizosaccharomyces pombe possesses a single IQGAP, termed 
Rng2, which is involved in the formation and contraction of the actomyosin ring during 
cytokinesis. Rng2 together with other kinases allows the maturation of cytokinesis proteins, 
called nodes, which results in the recruitment of actin and myosin to the contractile ring.  
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The localization of Rng2 to the nodes is dependent on the GRD and RCG domain in the C-terminal 
part of the IQGAP protein. Nodes condense into bundles, reorganize the plasma membrane and 
permit the separation of the cell into two daughter cells 113, 114, 115. Likewise, in the budding yeast 
Saccharomyces cerevisiae, Iqg1/Cyk1 is the only member of the IQGAP family. Iqg1 is also 
responsible for the recruitment of actin and myosin to the contractile ring at the cell division 
site 116, 117. Interestingly, in D. discoideum, three of four identified proteins have been 
characterized and termed DdIQGAP1, DdIQGAP2 and DdIQGAP3. DdIQGAP1 has an impact on cell 
polarity and regulation of the actin cytoskeleton by modulating the Rho GTPase Rac1 118. 
DdIQGAP2, together with DdIQGAP1 and DdIQGAP3, which have overlapping functions, is 
implicated in chemotaxis and cell motility 119. 
 
Figure 8. The domain structure of IQGAP proteins in mammals, yeast and amoebae.  
Schematic diagrams of human IQGAP1 and homologues are represented showing the regions of 
interactions with in vitro identified target proteins.  
Abbreviations: AA: amino acid; CHD: calponin homology domain; GRD: Ras GTPase-activating protein-
related domain; IQ: IQ domain containing four IQ motifs; RCG: RasGAP C-terminal; WW: polyproline 
binding domain. Numbers correspond to amino acid residues. Homologues of IQGAP proteins have been 
identified in other species: B, Rng2 in S. pombe; C, Iqg1 in S. cerevisiae and D, DdIQGAP1 
in D. discoideum. 
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b. The Rho family of GTPases 
IQGAP1 is a Ras GTPase activating protein which can bind to many target proteins and 
regulate several cell functions. It targets Rho GTPases like Cdc42 (Cdc42-GTP), Rac1, but also E- 
and β-cadherin, CLIP170 as well as actin. Rho family GTPases are key regulators in cell migration, 
polarization and reorganization in the microtubule and actin network, essential steps during 
inflammation reactions, wound healing, development and tumor invasion.  
Cdc42, Rac1 and RhoA are the best characterized and most important small GTPases during cell 
migration 120. These GTPases cycle between an inactive GDP-bound form and an active GTP-form. 
The GTPase activity is regulated through GEFs, GAPs and GDIs (GDP dissociation inhibitors). 
Approximately 80 GEFs have been identified in the human genome and can be classified into two 
families, the Dbl family with 69 members and the DOCK family with 11 members 121. Proteins of 
the Dbl family, which function upstream of Rho GTPases, share a Dbl homology (DH) catalytic 
domain responsible for the GDP-GTP exchange reaction and a pleckstrin homology (PH) domain 
located C-terminally to the DH domain. -PIX (PAK interacting exchange factor) is the best 
described family member and activates Cdc42 and Rac1 122. DOCK family proteins, divided into 
four groups (DOCK A-D), contain a Dock homology region 1 and 2, DHR1 and DHR2, which play a 
similar role as the PH-DH domain of Dbl proteins. DHR1 is essential for phospholipid binding and 
DHR2 for the GEF activity. DOCK A and B members possess a N-terminal Src homology (SH3) 
domain and mostly act on Rac1 (DOCK180), whereas DOCK D members (DOCK9 and 10) 
preferentially activate Cdc42 123, 124. Little is known about members of the DOCK C group. Table 1 
summarizes the Rho-GEFs, GAPs and GDIs most significant for cell migration 112, 125, 126, 127, 128, 129. 
Importantly, however, IQGAP1 does not function as a normal GAP by ending the signaling activity 
of RhoGTPases, but is able to inhibit the GTPase activity of Cdc42 and stabilizing it in its active 
GTP-bound form 130. 
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Table 1. RhoGEFs, GAPs and GDIs involved in cell migration.  
Abbreviations:  Asef: APC-stimulated guanine exchange factor 1; Cdc42: cell division control protein 42; 
DOCK: dedicator of cytokinesis; Ect2: epithelial cell transforming sequence 2 oncogene; GAP: GTPase 
activating protein; GDI: guanosine nucleotide dissociation inhibitor; GEF: guanine nucleotide exchange 
factor; PIX: PAK interacting exchange factor; Rac1: Ras-related C3 botulinum toxin substrate 1; 
Tiam1: T-lymphoma invasion and metastasis-inducing protein1.  
 
c. Effect of quorum sensing signals on cell migration 
Recently, it was described that bacterial QS signals (section C.2.a.) have an impact on the 
behavior of human cells. The QS AHL molecule N-acylhomoserine lactone from the Gram-
negative bacterium P. aeruginosa impaires the migration of intestinal epithelial cells by 
interacting with IQGAP1 and inducing changes in the phosphorylation pattern of Cdc42 and Rac1. 
Furthermore, the AHL signal influences the localization of IQGAP1 in the cell and also colocalizes 
with the protein. Cdc42- and Rac1-dependent dynamics of the actin cytoskeleton are altered and 
help the bacterium to invade and infect more efficiently the cell itself and neighbouring cells. 
Only cell migration seems to be modified and not cell proliferation or viability 102. 
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The immune-modulatory effect of AHL is reflected by an up-regulation of the production of pro-
inflammatory cytokines like IL-6 (interleukin-6) in bronchial epithelial cells of a cystic fibrosis 
lung 131. Additionally, AHL molecules induce apoptosis coordinated by an increase of cytosolic 
calcium 132. Surprisingly, the effect of homoserine lactone molecules depends on the exposed cell 
type. Paes et al., describe a positive influence of the QS signal from P. aeruginosa regarding re-
epithelialization 133. Migration of keratinocytes is improved during wound healing due to an 
enhanced expression of the matrix metallopeptidase 13 (Mmp13) gene dependent on the 
activator protein 1 (AP1) signaling pathway. In conclusion, QS molecules trigger, through inter-
kingdom signaling, essential changes in the migration behavior of immune cells by altering crucial 
steps during the regulation of actin cytoskeleton, calcium signaling and immune responses in 
which IQGAP1 and RhoGTPases seem to be main actors. 
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D. Aims of the thesis 
Cell migration and chemotaxis play major roles in a broad range of physiological events 
including immune responses against bacterial invaders. L. pneumophila is able to translocate 
approximately 300 different effector proteins into host cells, thus influencing their migration 
behavior. The aim of this thesis was to gain insights into the modulation of immune cell 
migration after a L. pneumophila infection. By the use of murine macrophages, neutrophils and 
D. discoideum amoebae, the influence of the bacteria on directed migration was to be examined 
through the analysis of the forward migration index and velocity in chemotactic under-agarose 
assays. Previous work demonstrated that the effector protein LegG1 is able to activate the small 
Ran GTPase and to interfere with the microtubule network. Another goal was to test the possible 
Ran-dependent effect of LegG1 on cell motility and thus on microtubule polymerization.  
Furthermore, L. pneumophila is capable to perform cell-cell communication via the production 
and sensing of the signaling molecule LAI-1. An additional aspect analyzed in this work was the 
influence of LAI-1 on host cell migration. The aim was to increase our knowledge regarding the 
motility parameters affected and host cell proteins involved in the signaling cascade of LAI-1.  
This thesis provides new insights into these processes and allowed the identification of 
implicated bacterial effector proteins and compounds involved in inter-kingdom signaling. 
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II. Materials and Methods 
A.   Materials 
1. Laboratory equipment 
Table 2. Equipment 
Equipment Manufacturer 
Autoclave Varioklav classic  H+P (Oberschleißheim) 
Benchtop centrifuge 5417R  Eppendorf (Hamburg) 
Confocal microscope Leica TCS SP5  Leica (Mannheim) 
Culture microscope Primo Vert  Zeiss (Oberkochen) 
Electrophoresis chamber Mini-Protean 3 Bio-Rad (Munich) 
Gel imaging system ChemiDoc MP System Bio-Rad (Munich) 
Gel imaging system GelDoc EQ Bio-Rad (Munich) 
Hot plate magnetic stirrer RCT basic IKA (Staufen) 
Ice maker AF30 Scotsman (Vernon Hills) 
Incubator Heraeus BR6000  Thermo (Waltham) 
Incubator Heraeus Function Line  Thermo (Waltham) 
Incubator IPP500  Memmert (Schwabach) 
pH-meter Level 1 inoLab (Weilheim) 
Pipettes Pipetman  Gilson (Middleton) 
Pipettor Pipetus  Hirschmann (Eberstadt) 
Power supply PAC100  Bio-Rad (Munich) 
Precision balance BP61-S Sartorius (Goettingen) 
Precision balance PG2002-S Mettler-Toledo (Greifensee) 
Spectrophotometer Helios Epsilon Thermo (Waltham) 
Water bath 1005  GFL (Burgwedel) 
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2. Chemicals and consumables 
Table 3. Chemicals and consumables 
Material Manufacturer 
ACES  AppliChem (Darmstadt) 
Acrylamid/bisacrylamid  Serva (Heidelberg) 
Activated charcoal powder  Fluka (Buchs) 
Agar  BD Biosciences (Franklin Lakes) 
Agarose Ultra Pure  Life Technologies (Darmstadt) 
Alexa Fluor 488 Phalloidin Molecular Probes  Life Technologies (Darmstadt) 
Bacteriological peptone  BD Difco (Heidelberg) 
Bacteriological peptone  Oxoid (Wesel) 
Bacto proteose peptone BD Biosciences (Franklin Lakes) 
Bacto yeast extract  BD Biosciences (Franklin Lakes) 
BBL yeast extract  BD Biosciences (Franklin Lakes) 
Bovine serum albumin (BSA) AppliChem (Darmstadt) 
β-mercaptoethanol  AppliChem (Darmstadt) 
CCL5 recombinant protein Life Technologies (Darmstadt) 
D(+)-glucose monohydrate  Fluka (Buchs) 
ECL detection kit  GE Healthcare (Chalfont St Giles) 
FCS (fecal calf serum) Life Technologies (Grand Island) 
FeN3O9 x 9 H2O Sigma (St. Louis) 
fMLP provided by  AG Haas (Munich) 
Folic acid  Sigma (St. Louis) 
Glycine  MP Biomedicals (Eschwege) 
HBSS Life Technologies (Grand Island) 
HiPerFect Transfection Reagent  Qiagen (Hilden) 
Histopaque 1077  Sigma (St. Louis) 
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Histopaque 1119  Sigma (St. Louis) 
IL-8 recombinant protein  Life Technologies (Darmstadt) 
K2HPO4  Fluka (Buchs) 
KH2PO4  Fluka (Buchs) 
LB agar  Life Technologies (Grand Island) 
LB broth base  Life Technologies (Grand Island) 
L-cysteine  Sigma (St. Louis) 
L-glutamine Life Technologies (Grand Island) 
MES Buffer Sigma (St. Louis) 
MgSO4  Fluka (Buchs) 
Na2HPO4  Fluka (Buchs) 
PFA  Sigma (St. Louis) 
Plastic luer lock syringes (10 mL)  BD Biosciences (Franklin Lakes) 
poly-L-lysine  Sigma (St. Louis) 
Protein A/G PLUS-agarose reagent  Santa Cruz (Heidelberg) 
Protein ladder (PageRuler prestained 10-190K)  Thermo (Waltham) 
RPMI 1640 Life Technologies (Grand Island) 
SDS  Serva (Heidelberg) 
TNFα recombinant protein  Life Technologies (Darmstadt) 
TEMED  Biomol Feinchemikalien (Hamburg) 
TRIS MP  Biomedicals (Santa Ana) 
Trypsin  Life Technologies (Grand Island) 
Vectashield mounting medium  Vector Laboratories (Cambridgeshire) 
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3. Medium and buffer composition 
a. Media 
Table 4. AYE (ACES yeast extract) medium 
Component Per Liter medium Supplier 
ACES 10 g  AppliChem 
Bacto yeast extract 10 g  BD biosciences 
L-cysteine 0.4 g Sigma 
FeN3O9 x 9H2O 0.25 g Sigma 
 
ACES and yeast extract were dissolved in 900 mL H2O, cysteine and iron separately in 10 mL H2O. 
First, the cysteine solution and iron were added slowly while stirring. The pH was adjusted to 6.9 
with 10 M KOH. Then, H2O was added to reach end volume. The medium was sterilized through 
glass fiber filter 2 times and stored at 4 °C 43. 
 
Table 5. CYE (charcoal yeast extract) agar plates 
Component Per Liter medium Supplier 
ACES 10 g AppliChem 
Bacto yeast extract 10 g BD biosciences 
Activated charcoal puriss p.a. ; powder 2 g Fluka 
Agar 15 g BD biosciences 
L-cysteine 0.4 g 10 mL-1 Sigma 
FeN3O9 x 9H2O 0.25 g 10 mL
-1 Sigma 
 
ACES and yeast extract were mixed in H2O and the pH was adjusted to 6.9 with 10 M KOH. H2O 
was added to reach end volume. After the addition of activated charcoal and agar, the medium 
was autoclaved and cooled to 50 °C. The filter-sterilized L-cysteine and iron were added. If 
necessary, chloramphenicol was supplemented to an end concentration of 5 mg L-1. Plates were 
stored at 4 °C 134. 
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Table 6. HL5 medium 
Component Per Liter medium Supplier 
D(+)-glucose monohydrate  11 g Fluka 
BBL yeast extract  5 g BD Biosciences 
Bacto proteose peptone  5 g BD Biosciences 
Bacteriological peptone  5 g Oxoid 
Na2HPO4  0.355 g  Fluka 
KH2PO4  0.34 g  Fluka 
 
The pH was adjusted to 6.5 with 1 M KOH or 1 M HCl. The medium was autoclaved and stored at 
4°C 135. 
 
Table 7. MB medium 
Component Per Liter medium Supplier 
BBL yeast extract  7 g BD Biosciences 
Bacteriological peptone  14 g Oxoid 
MES buffer 4.26 g Sigma 
 
The pH was adjusted to 6.9 with 1 M KOH or 1 M HCl. The medium was autoclaved and stored at 
4 °C 136. 
 
Table 8. SM medium 
Component Per Liter medium Supplier 
Bacteriological peptone  10 g Oxoid 
BBL yeast extract  1 g BD Biosciences 
KH2PO4 1.9 g Fluka 
K2HPO4 0.6 g Fluka 
MgSO4 0.43 g Fluka 
 
 
 
 
 
 
After adjusting the pH to 6.0 with KOH, the medium was stored at 4 °C 137. 
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b. Buffers 
Table 9. PBS (phosphate-buffered saline) 10 x 
Component Per Liter buffer Supplier 
NaCl   80 g Roth 
KCl  2 g  Roth 
Na2HPO4   14.2 g Fluka 
KH2PO4  2.4 g Fluka 
 
The pH was adjusted to 7.4 with 1 M NaOH or 1 M HCl. The buffer autoclaved and stored at room 
temperature. 
 
Table 10. SorC 
Component Per Liter buffer Supplier 
Na2HPO4  0.28 g Fluka 
KH2PO4   2.04 g Fluka 
CaCl2 x 2 H2O   0.00735 g  Roth 
 
After adjusting the pH to 6.0 with 1 M KOH or 1 M HCl, the buffer was autoclaved and stored at 
room temperature 138. 
 
Table 11. TBS (TRIS-buffered saline) 10 x 
Component Per Liter buffer Supplier 
TRIS 6.5 g MP Biomedicals 
NaCl  80 g Roth 
 
The pH was adjusted to 7.5 with HCl and the buffer autoclaved and stored at 4°C. 
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4. Strains and plasmids 
Table 12. Mammalian cells lines and bacterial strains 
Strain Properties  Reference 
 
   
Mammalian cell lines 
   
A549 Human alveolar basal   gift from U. Greber (Zurich) 
 
epithelial cells 
 
   HeLa Human cervix  gift from U. Greber (Zurich) 
 
adenocarcinoma cells  
 
   RAW 264.7  Murine macrophage cell line  ATCC TIB-71 
 
 
  Dictyostelium discoideum 
   
Ax3 pSW102 
 
G418 resistant (R) 53 
Ax2/ GFP-α-tubulin G418R 139 
 
 
  Bacteria 
  
   L. longbeachae 
  
NSW150 L. longbeachae   140 
 
sg 1 clinical isolate, Australia 
 
NSW150ΔdotA NSW dotA::KanR  140 
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L. pneumophila 
  
AK01 (ΔlqsT) JR32 lqsT::KanR 105 
AK02 (ΔlqsS/lqsT) JR32 lqsS::Km lqsT::GenR 105 
CR01 (ΔsidC-sdcA) JR32 sidC-sdcA::KanR  50 
CR04 (ΔsidM/drrA) JR32 sidM/drrA::KanR  52 
ER01 (ΔlegG1) JR32 legG1::KanR  18 
GS3011 (ΔicmT) L. pneumophila  141 
 
JR32 icmT3011::KanR 
 
JR32 L. pneumophila  142 
 
sg 1 Philadelphia 
 
MW635 (ΔicmG) JR32 icmG::KanR  143 
NT02 (ΔlqsA) JR32 lqsA:: KanR 107 
NT03 (ΔlqsR) JR32 lqsR:: KanR 107 
NT05 (ΔlqsS) JR32 lqsS:: KanR 107 
 
Table 13. Plasmids 
Plasmid  Characterization Sequence 
pCR33 pMMB207C-M45, CamR 48 
pCR34 pMMB207C-M45-sidC 48 
pCR76 pMMB207C-Ptac-RBS-gfp-RBS-MCS 
19 
pCR77 pMMB207C-Ptac-RBS-dsred-RBS-MCS 
19 
pEB201 pMMB207C-M45-sidM 52 
pER4 pCR76-M45-legG1 18 
pER5 pCR77-M45-legG1 18 
pER22 pSW001-Plpg1775-lpg1775-lpg1776 
144
 
pGP3 pCJYE53-G3-legG1, CamR 18 
pGP4 pCJYE138-G3-legG1, CamR 18 
pSW001 pMMB207-C-RBS-dsred (constitutive dsred) 145 
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5. Antibodies 
a. Primary antibodies 
Table 14. Primary antibodies 
Antibody Origin Supplier 
anti-ARHGAP1 rabbit  Abcam (Cambridge) 
anti-ARHGAP17 rabbit Abcam (Cambridge) 
anti-ARHGEF9 rabbit Abcam (Cambridge) 
anti-Cdc42 rabbit Abcam (Cambridge) 
anti-Cdc42(GTP) mouse Biomol (Hamburg) 
anti-Cdc42/Rac1-phosphoS71 rabbit Abcam (Cambridge) 
anti-GAPDH rabbit Cell Signaling (Leiden) 
anti-IQGAP1 rabbit Abcam (Cambridge) 
anti-Rac1 rabbit Abcam (Cambridge) 
anti-Ran rabbit Abcam (Cambridge) 
anti-RanBP1 rabbit Abcam (Cambridge) 
anti-RhoA rabbit Abcam (Cambridge) 
anti-tubulin WA3 mouse AG Taubenberger (Munich) 
 
b. Secondary antibodies 
Table 15. Secondary antibodies 
Antibody Origin Label Supplier 
anti-rabbit IgG  goat FITC Jackson ImmunoResearch (West Grove) 
anti-rabbit IgG  goat Cy5 Life Technologies (Darmstadt) 
anti-mouse IgG goat FITC Jackson ImmunoResearch (West Grove) 
anti-mouse IgG goat Cy5 Jackson ImmunoResearch (West Grove) 
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6. Oligonucleotides used for RNAi 
Table 16. Oligonucleotides 
Target 
gene 
Gene description 
Entrez 
Gene ID 
Product name Product ID 
ARHGAP1 Rho GTPase activating protein 1 392 Hs_ARHGAP1_5 SI03233797 
   
Hs_ARHGAP1_6 SI04144126 
   
Hs_ARHGAP1_7 SI0416481 
   
Hs_ARHGAP1_8 SI04177754 
     
ARHGAP17 Rho GTPase activating protein 17 70497 Hs_ARHGAP17_1 SI00302001 
   
Hs_ARHGAP17_3 SI00302036 
   
Hs_ARHGAP17_4 SI00302043 
   
Hs_ARHGAP17_5 SI02780449 
     
ARHGEF9 Cdc42 guanine nucleotide 23229 Hs_ARHGEF9_5 SI04138498 
 
 exchange factor 
 
Hs_ARHGEF9_7 SI04210689 
   
Hs_ARHGEF9_10 SI05428654 
   
Hs_ARHGEF9_11 SI05428661 
     
Cdc42 Cell division cycle protein 42 998 Hs_CDC42_4 SI00028413   
   
Hs_CDC42_7 SI02757328 
   
Hs_CDC42_15 SI04381671 
   
Hs_CDC42_17 SI04948440   
     
DOCK11 Dedicator of cytokinesis 11 139818 Hs_DOCK11_5 SI04157202 
   
Hs_DOCK11_6 SI04257743 
   
Hs_DOCK11_7 SI04277035 
   
Hs_DOCK11_8 SI04330795 
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FGD1 FYVE, RhoGEF and  2245 Hs_FGD1_2 SI00386568 
 
PH domain containing 1 
 
Hs_FGD1_5 SI03170818 
   
Hs_FGD1_7 SI04203192 
   
Hs_FGD1_9 SI04280087 
     
IQGAP1 IQ motif containing  8826 Hs_IQGAP1_1 SI00057036 
 
GTPase activating protein 1  
 
Hs_IQGAP1_2 SI00057043 
   
Hs_IQGAP1_3 SI00057050 
   
Hs_IQGAP1_5 SI02655268   
     
Rac1 Ras-related C3  5879 Hs_RAC1_5 SI02638293   
 
botulinum toxin substrate 1  
 
Hs_RAC1_6 SI02655051 
   
Hs_RAC1_7 SI03037524   
   
Hs_RAC1_8 SI03040884   
     
Ran Ras-related nuclear protein 5901 Hs_RAN_7  SI04950498 
   
Hs_RAN_8 SI04950505 
   
Hs_RAN_9 SI04950512 
   
Hs_RAN_10 SI04950519 
     
RanBP1 Ras binding protein 1 5902 Hs_RANBP1_3  SI00698201 
   
Hs_RANBP1_4  SI00698208 
   
Hs_RANBP1_6  SI03188381 
   
Hs_RANBP1_7  SI04142089 
     
RhoA Ras homolog family member A 387 Hs_RHOA_1 SI00702695   
   
Hs_RHOA_6 SI02654211 
   
Hs_RHOA_7 SI02654267   
   
Hs_RHOA_8 SI02776907 
 
 
    Materials and Methods 
37 
 
B. Methods 
1. Cultivation of L. pneumophila and L. longbeachae 
L. pneumophila and L. longbeachae strains were grown at 37 °C on CYE agar plates 
containing charcoal and yeast extract buffered with ACES 134. After 3 days of cultivation on plates, 
3 mL of AYE liquid medium were inoculated with L. pneumophila at a starting OD600 of 0.1 and 
aerobically grown at 37 °C on a turning wheel. Chloramphenicol (5 µg mL-1) or IPTG (1 mM) were 
added for selection. After 21-22 h and at an OD600 of 3.0, the bacteria reached their most 
infectious state. After 18 h at 37 °C, liquid cultures of Legionella spp. reached an OD600 of 2.5 and 
were mixed 1:1 with sterile 50% glycerol and permanently stored at -80 °C.  
 
2. Cell cultivation and storage 
a. Mammalian cells 
Murine RAW 264.7 macrophages, human A549 lung epithelial cells and HeLa cervix 
carcinoma cells were cultivated in RPMI 1640 medium amended with 10% FCS (heat inactivated 
fetal calf serum) and L-glutamine (2 mM) at 37 °C under 5% CO2. For passaging, cells were 
scratched with a cell scraper or detached with trypsin from the surface (3 mL for one 75 cm2 
flask). 80% confluent cells were harvested and resuspended in 3 mL freezing medium (70% 
RPMI 1640, 20% FCS, 10% DMSO). Cryogenic vials were filled with 1 mL of cells and placed in a 
freezing box (containing isopropanol, precooled for 1 h at 4 °C). After freezing overnight at -80 °C, 
they were stored in liquid N2. For thawing, cells were centrifuged and replaced by RPMI 1640 
culture medium to eliminate toxic DMSO present in the freezing solution. 
 
b. Dictyostelium discoideum 
The D. discoideum Ax3 pSW102 strain was grown in HL5 medium at 23 °C and 
supplemented with G418 (20 µg mL-1) for selection. Amoebae were detached mechanically 135. 
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Confluent D. discoideum cells were resuspended in 1 mL freezing medium (80% HL5, 10% FCS, 
10% DMSO) and filled into cryogenic vials. Storage and thawing was performed as described for 
mammalian cells (section B.1.) 
 
3. Neutrophil isolation 
The HISTOPAQUE reagents (1119 and 1077, Sigma-Aldrich) were used for leukocyte 
separation and isolation of neutrophils. 3 mL of HISTOPAQUE-1119 was added, carefully layered 
by 3 mL of HISTOPAQUE-1077 and 6 mL of freshly isolated human blood in a 15 mL conical 
centrifuge tube. The tube was centrifuged at 700 x g without brake at room temperature for 
30 min. Layers could be observed, in the following order from the top to the bottom of the tube: 
blood plasma, mononuclear cells/platelets, HISTOPAQUE-1077, granulocytes (including 
neutrophils), HISTOPAQUE-1119 and erythrocytes. Fluid remaining on the top of the cells of 
interest was aspirated and discarded. Granulocytes were then transferred to a new tube and 
washed with 10 mL of isotonic PBS. After centrifugation (200 x g, 10 min, 3 times), the cells were 
resuspended in buffered saline 146. This step was repeated three times. After the final 
centrifugation step, neutrophils were resuspended in RPMI medium and used for migration 
assays. 
4. Aggregation assay 
For starvation/aggregation assays, D. discoideum Ax3 cells (5 x 106) were grown in 6-well 
plates in HL5 medium the day before infection. Cells were washed two times with SorC and 
infected with the indicated L. pneumophila strains at an MOI of 10. After 1 h, extracellular 
bacteria were removed by washing two times with SorC. To permit aggregation and 
development, cells were further incubated in SorC at 23 °C for 12 to 48 h and stained with 
propidium iodide (PI, 2.5 µg mL-1, 10 min, 23 °C) prior to fluorescence microscopy. 
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5. Migration assays 
a. Under-agarose assay and single cell tracking 
Under-agarose assays were performed as previously described 147, 148.  D. discoideum 
cells, murine RAW 264.7 macrophages and human neutrophils were used for the assay.  
For Ax3 pSW102 (GFP) amoebae, microscopy dishes (µ-Dish, 35 mm, Ibidi) were filled with a 
mixture of melted agarose in SM medium. After solidification (30 min), parallel slots (2 x 4 mm, 
5 mm apart) were cut into the agarose. The chemoattractant solution, folic acid (1 mM) diluted in 
SM medium, was filled into the central slot. After 30 min, D. discoideum cells (30 µL) were filled 
into the neighboring slots. Prior to the experiment, 1 x 106 cells were seeded into a 6-well plate in 
HL5 medium, treated and/or infected with L. pneumophila. For the migration assay, cells were 
washed once with MB medium. The infection was performed for 1 h at an MOI of 10 at 23 °C. 
After the incubation time and two washing steps with MB to remove extracellular bacteria, the 
amoebae were detached by scratching in 500 µL MB medium. Then, the dishes were incubated in 
a humid chamber to allow cell migration at 23°C for 4 h. 
For under-agarose assays using RAW 264.7 macrophages, the dishes were incubated with 10% 
FCS solution at room temperature for 30 min. After two washing steps with PBS, the dishes were 
filled with a mixture of 1% UltraPure Agarose/RPMI/HBSS (Life Technologies). Three parallel wells 
(5 mm apart) were formed using a template. Before the cells were filled into the neighbouring 
slots, the chemoattractant solution (CCL5 or TNFα 100 ng mL-1 for macrophages and the peptide 
formyl-methionyl-leucyl-phenylalanine (fMLP) 100 ng mL-1 for neutrophils, Invitrogen) was 
prefilled in the middle well for 45 min. The day before the infection with L. pneumophila (1 h, 
37 °C), 1 x 106 macrophages or neutrophils were seeded into a 6-well plate in RPMI medium. 
Cells were washed once with RPMI, incubated for 45 min with a CellTracker Green BODIPY and 
after another washing step kept in 3 mL medium for the infection. Cells were washed twice with 
RPMI to remove extracellular bacteria, detached by scratching and resuspended into 500 µL 
RPMI medium. 150 µL of the cell suspension was filled into the slots. The dishes were incubated 
in a humid chamber at 37 °C for 4 h.  
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Under-agarose cell migration was monitored by detecting the green BODIPY fluorescence of 
macrophages or the GFP fluorescence of D. discoideum with the 10x objective of a Leica TCS SP5 
microscope. The tile scan function of the Leica software allowed us to obtain merged overview 
pictures. The quantification of cell migration was documented with the ImageJ software using the 
plot profile function. The fluorescence intensities of infected cells relative to uninfected cells 
were plotted against the migration distance. 
Tracking of migrating D. discoideum, RAW 264.7 macrophages or human neutrophils was 
recorded 1 h after the cells were filled into the slots by confocal microscopy (HCX PL APO CS 
40x/1.25 oil UV objective). Migrating D. discoideum cells were recorded for 15 min within a 2 h 
time window by taking 1 frame per 25 sec. Macrophages and human neutrophils were followed 
for 1 h with 1 frame per 35 sec at 2 h post infection. Cells were tracked using the ImageJ manual 
tracking plugin and analyzed with the Chemotaxis and Migration Tool 2.0 (Ibidi). 
 
b. Boyden chamber assay 
One day prior to the experiment, cells were seeded into a 6 well plate in RPMI medium. 
Cells were washed once and detached by scratching. In this assay, inserts with a pore size of 8 µm 
were placed into a 24-well plate. The chemoattractant solution (fMLP for neutrophils) was placed 
into the lower part, whereas cells were placed in the upper part of the well. Cells were allowed to 
migrate towards the chemoattractant for 3-4 h. In order to determine the number of 
transmigrating cells, a Neubauer chamber was used. 
c. Scratch assay 
In vitro scratch assays were performed as described before (Liang et al., 2007). Briefly, 
A549 epithelial cells were seeded into 35 mm μ-Dishes (Ibidi) at a density of 1.5 × 105 cells mL−1 
(3 × 105 cells dish-1) and incubated for 24 h at 37 °C. Confluent cell layers were washed with fresh 
RPMI medium and infected with L. pneumophila strains at an MOI of 10 and/or treated with 
10  µM LAI-1 for 90 min. After the infection and/or compound treatment, the cell layer was 
scratched with a sterile pipette tip and washed with fresh medium to remove detached cells.  
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Images of the scratched positions were taken with a Leica SP5 confocal microscope (HCX PL APO 
CS 10×/ 0.40 dry UV objective) 0 h and 24 h after.  
The percentage of scratch closure was quantified with the ImageJ software (function analyze 
particles) by comparing the remaining scratch area with the initial cell-free scratch area. 
 
6. RNA interference 
For RNA interference experiments in scratch assays, A549 cells were grown in 35 mm μ-
Dishes (Ibidi) and treated for 48 h with a mixture of four siRNA (Qiagen) oligonucleotides with the 
final concentration of 10 nM 149. The siRNA stock (10 µM) was diluted 1:15 in RNase-free water 
and 22.5 µL of diluted siRNA was added in each well. Allstars negative control siRNA was used as 
a negative control. Subsequently, 181.9 µL RPMI medium without FCS were mixed with 5.6 µL 
HiPerFect transfection reagent (Qiagen), added to the well, mixed and incubated for 5-10 min at 
room temperature. In the meantime, cells were diluted in RPMI medium (with 10% FCS) and 
1.312 mL (1.5 × 105 cells mL-1) were added on top of each siRNA-HiPerFect transfection complex 
and incubated for 48 h. After a washing step with RPMI medium, cells were infected with 
L. pneumophila strains and/or treated with 10 µM LAI-1. The scratch assay was performed as 
described above (section B.5.c). The depletion efficiency of all siRNA oligonucleotides was 
assessed by Western blot. In growth assays, A549 cells were grown in 96-well plates and treated 
for 48 h with a final concentration of 10 nM of the siRNA oligonucleotides. The siRNA stock 
(10 µM) was diluted 1:15 in RNase-free water, and 3 µL of the diluted siRNA was added in each 
well. Allstars siRNA was used as a negative control. Subsequently, 24.25 µL RPMI medium without 
FCS was mixed with 0.75 µL HiPerFect transfection reagent (Qiagen), added to each well, mixed 
and incubated for 5-10 min at RT. In the meantime, cells were diluted in RPMI medium (with 10% 
FCS), 175 µL of the diluted cells (2 × 104 cells) was added on top of each siRNA-HiPerFect 
transfection complex and incubated for 48 h. The cells were then infected at an MOI of 10 with 
GFP-producing L. pneumophila grown for 21 h, diluted in RPMI, centrifuged and incubated for 1 h 
at 37 °C. After three washing steps with RPMI medium (containing 10% FCS), the cells were 
incubated for 48 h. Intracellular bacterial growth was analyzed by measuring fluorescence using a 
plate reader (FluoStar Optima, BMG Labtech). 
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7. Immuno-fluorescence  
For immunofluorescence analysis, A549 cells were seeded onto coverslips in 24 well 
plates and treated with LAI-1 (10 µM). Non-treated A549 cells served as control. L. pneumophila 
overnight cultures (wild-type or ΔicmT) were diluted in RPMI medium and used for infection at an 
MOI of 10 at 37 °C for 1 h. Cells were fixed with 3% paraformaldehyde for 15 min, washed three 
times with PBS, permeabilized with 0.1% Triton X-100 (in PBS) and blocked with 1% BSA. Cells 
were incubated with primary antibodies diluted in blocking buffer against IQGAP1, 
Cdc42(GTP/GDP) or Cdc42-Ser71 (each 1:2500, overnight at 4°C). Cells were incubated (1 h, at 
room temperature, in the dark) with appropriate secondary antibodies diluted (1:500) in blocking 
buffer and coupled to FITC or Cy5. After three washing steps, coverslips were mounted with 
Vectashield supplemented with 1 µg mL-1 DAPI to stain the nucleus and analyzed with a Leica TCS 
SP5 confocal microscope. Microtubule cytoskeleton examination was performed with RAW 264.7 
macrophages, infected or not with L. pneumophila (MOI 10, 1 h). After a washing step with 
Brb80, cells were fixed (50% Brb80, 0.1% Triton X-100, 0.5% glutaraldehyde) for 5 min. After 
washing with SorC, samples were blocked with 1 mg ml-1 sodium borohydrate in SorC for 10 min, 
subsequently stained with the anti-α -tubulin antibody WA3 (provided by M. Schleicher). And 
appropriate secondary antibodies (1:200). RAW 264.7 macrophages were seeded on coverslips in 
a 24 well-plate and stained with Texas red-phalloidin. Actin was visualized after washing steps 
with PBS, permeabilization with cold 1% Triton X-100/PBS for 3-5 min and blocking with 1% BSA. 
Nuclei were stained with DAPI (0.1 µg mL-1). Imaging was accomplished by confocal microscopy. 
 
8. Pulldown experiments and Western Blot 
In order to identify Cdc42(GTP) and Cdc42(GDP) in epithelial cells, pulldown experiments 
using reagents from Santa Cruz (Protein A/G PLUS-Agarose) were performed.  
A549 cells were treated with ice cold RIPA buffer and incubated at 4 °C for 10 min. Cellular debris 
were precipitated by centrifugation (10 min, 10000 x g, 4 °C).  
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The supernatant was transferred to a fresh tube on ice, together with 20 µL of resuspended 
volume of Protein A/G PLUS Agarose and incubated for 30 min at 4 °C. Beads were precipitated 
by centrifugation (5 min, 2000 x g, 4 °C) and 1 mL (approximately 100 – 500 µg total cell protein) 
of the supernatant was incubated for 1 h at 4 °C with the primary antibody (Abcam, 1:1000) anti-
Cdc42(GTP/GDP). 20 µL of resuspended AG PLUS Agarose was added followed by an incubation 
step on a rotating device for 1 h at 4 °C.  Immunoprecipitates were collected by centrifugation 
(2000 x g) for 5 min at 4 °C and the pellet was washed 4 times with 1 mL of RIPA buffer. After the 
final washing step, the pellet was resuspended in 40 µL of loading buffer. After a boiling step of 
2-3 min, samples were subjected to SDS-PAGE and analyzed by Western Blot analysis using 
antibodies against anti-Cdc42(GTP/GDP) or anti-Cdc42(GTP), (both 1:1000). A GAPDH control 
(Abcam, 1:1000) was used to test the initial amount of protein 18. 
 
9. Uptake and cytotoxicity assays 
For uptake experiments, D. discoideum cells (5 × 105), RAW 264.7 macrophages or human 
neutrophils (2.5 × 105) were infected at an MOI of 10 for 1 h with GFP producing L. pneumophila 
wild-type or ∆icmT mutant bacteria and/or treated with different concentrations of LAI-1 (1, 5 or 
10 µM). Fluorescence of GFP-positive phagocytes harboring L. pneumophila was determined by 
flow cytometry. The percentage of cells with GFP fluorescence above the defined threshold was 
depicted. The cytotoxicity of L. pneumophila (MOI 10, 4 h) strains using different concentrations 
of LAI-1 was examined for D. discoideum, macrophages or neutrophils in 24 well plates. Cells 
were collected into 15 mL tubes and resuspended in 500 µL SorC (D. discoideum) or PBS 
(macrophages and neutrophils) after centrifugation (240 × g, 10 min). PI (2.5 µg µL-1) was added 
to the tubes and incubated for 10 min in the dark. PI-positive cells were quantified by flow 
cytometry 150. 
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III. Results 
A broad range of intracellular pathogens have been described to modulate immune cell 
migration in order to ensure their own survival and replication. For instance, the bacterium 
Yersinia pestis can act to inhibit neutrophils and dendritic cells chemotaxis by altering early host 
inflammatory responses 151, 152. The enteropathogen Salmonella enterica inhibits, via the type III 
secreted effector SseI, the migration of dendritic cells and primary macrophages 153. 
Furthermore, Shigella flexneri and bacteria of the genus Chlamydia impair the migration of CD4+ 
T lymphocytes. Additionaly, the motility of vascular smooth muscle cell is increased by the up-
regulation of IQGAP1 154. However, at the onset of this thesis, nothing was known about the 
influence of L. pneumophila on host cell migration. In order to promote their own growth, the 
invading bacteria modulate cell motility, chemotaxis and immune function by targeting, amongst 
other proteins, the action of small GTPases. Recent studies identified the L. pneumophila effector 
protein LegG1 as an activator of the host small GTPase Ran. The resulting major downstream 
effect is the stabilization of microtubule polymerization which is, together with cell polarization, 
crucial for proper chemotaxis 18.  
The data presented in the first part (A) of this thesis show that the Ran activator LegG1, an 
Icm/Dot translocated L. pneumophila protein, influences host cell migration and chemotaxis by 
interfering with microtubule polymerization 144. The second aspect of this work (B) contains an 
investigation of the effect of LAI-1, a L. pneumophila QS signal employed for cell-cell 
communication, on host cell chemotaxis and migration 206. 
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A. Icm/Dot-dependent inhibition of phagocyte migration by 
L. pneumophila  is antagonized by a translocated Ran 
GTPase activator 
1. Icm/Dot-dependent inhibition of D. discoideum and immune cell              
migration by L. pneumophila 
The first question which needed to be answered was whether Legionella affects host cell 
migration. To this end, D. discoideum cells producing the green fluorescent protein GFP 
(Ax3, pSW102) were infected with L. pneumophila wild-type or with a mutant strain lacking a 
functional Icm/Dot T4SS termed ΔicmT for 1 h at different multiplicities of infection (MOIs). In an 
under-agarose migration assay, the infected amoebae migrated towards folic acid (1 mM) for an 
additional 4 h (Figure 9A). The results showed that uninfected cells migrated over 1500 µm 
towards the chemoattractant. An infection with the wild-type strain inhibited the migration in a                    
MOI-dependent manner (approximately 1300 µm for an MOI of 1 and nearly no migration for an 
MOI of 50). In contrast, an infection with the ΔicmT strain did not alter the chemotaxis of 
D. discoideum cells, similar to the migration of uninfected cells (Figure 9B). Furthermore, the 
effect of L. pneumophila at early steps of the developmental process of D. discoideum was 
observed. Cells, normaly grown in rich HL5 medium, were transferred to nutrient poor SorC-
buffer and infected with L. pneumophila wild-type and ΔicmT (MOI 10, 1 h). After 12, 24 and 
48 h, aggregation of starved amoebae was determined following staining with propidium 
iodide (PI, Figure 9C). Uninfected and ΔicmT infected cells aggregated, formed streams and slugs 
which develop into stalks and fruiting bodies. This was not observed after an infection with the 
wild-type strain. These initial results suggest that L. pneumophila inhibits chemotaxis and 
aggregation of D. discoideum cells in an Icm/Dot- and MOI-dependent manner. 
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Figure 9. Icm/Dot-dependent 
inhibition of D. discoideum 
chemotaxis and aggregation by 
L. pneumophila.   
A. D. discoideum cells Ax3 harboring 
pSW102 (GFP) were infected with 
L. pneumophila wild-type or ΔicmT at 
different MOIs (1-50) for 1 h. Migration 
towards folic acid (1 mM) was 
monitored in an under-agarose assay 
for 4 h. The white lines represent the 
edge of the sample wells. 
B. Graph of the data from (A) 
represents the percentage of GFP 
fluorescence intensity versus migration 
distance. The data shown are 
representative of at least three 
independent experiments.  
C. D. discoideum cells grown in rich 
HL5 medium were placed in SorC 
buffer and infected for 1 h at an MOI of 
10 with L.  pneumophila wild-type or 
ΔicmT. Upon starvation and following 
staining with PI (2.5 µg mL
-1
), 
aggregation of the cells was recorded 
after 12, 24 and 48 h of incubation 
at 23 °C. 
 
As L. pneumophila is also able to infect mammalian phagocytes, the effect on immune cell 
migration was investigated. Murine RAW 264.7 macrophages (Figure 10A-B) and primary human 
neutrophils (PMN, Figure 10C) were first stained with a CellTracker Green BODIPY and infected 
with L. pneumophila wild-type or ΔicmT. Migration of the cells to different chemoattractants 
(CCL5 or TNFα for macrophages and fMLP for neutrophils) was analyzed in an under-agarose 
assay 4 h post-infection. For both cell types, the migration distance of uninfected cells and cells 
infected with the ΔicmT strain was approximately 500 µm. In contrast, migration of cells infected 
with wild-type L. pneumophila was completely abolished as observed for D. discoideum amoebae. 
Similar results were obtained for the Boyden chamber assay (Figure 10D).  
    Results 
47 
 
More than 1 x 106 uninfected or neutrophils infected with the ΔicmT mutant strain migrated 
through a culture insert (8 µm pore size) towards fMLP, whereas only approximately 2.5 x 105 
wild-type infected immune cells passed.  
 
 
 
Figure 10. Icm/Dot-dependent inhibition of macrophage and neutrophil migration by 
L. pneumophila.  
A. Murine RAW 264.7 macrophages were stained with CellTracker Green (BODIPY) and infected 
(MOI 10, 1 h) with L. pneumophila wild-type or ΔicmT mutant strain. Cells migrated towards CCL5 
(100 ng mL
-1
) in an under-agarose assay for 4 h. Graphs depict the percentage of fluorescence intensity 
versus migration distance.  
B. A similar experiment as described in (A) was performed using macrophages migrating towards 
TNFα (100 ng mL
-1
). 
C. Freshly isolated human neutrophils were infected (MOI 10, 1 h) and migrated in an under-agarose 
assay for another 4 h towards fMLP (100 ng mL
-1
).  
D. Human neutrophils were infected with L. pneumophila wild-type or ΔicmT and migration towards fMLP 
was analyzed in a Boyden chamber assay for 3 h using cell culture insert with a pore size of 8 µm. 
Means and standard deviations of three independent experiments are shown. Student´s t-test; * p < 0.05, 
** p < 0.01. 
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Additionally, the migration of murine macrophages infected with L. longbeachae wild-type or a 
T4SS deficient ΔdotA mutant showed the same effect as observed for L. pneumophila. The 
migration was also inhibited in an Icm/Dot-dependent manner (Figure 11). 
Taken together, these data revealed an Icm/Dot-dependent inhibition of D. discoideum and 
leukocyte chemotaxis by L. pneumophila and L. longbeachae. 
 
 
 
 
 
 
 
Figure 11. Icm/Dot-dependent 
inhibition of macrophage 
migration by L. longbeachae. 
A. Murine macrophages were 
infected (MOI 10, 1 h) with 
L. longbeachae wild-type or a 
ΔdotA mutant. For comparison, 
cells were infected with 
L. pneumophila wild-type or 
ΔicmT mutant. Cells were 
stained with the CellTracker 
Green BODIPY and allowed to 
migrate in an under-agarose 
assay for another 4 h towards 
TNFα (100 ng mL
-1
). The white 
lines represent the edge of the 
sample wells. 
B. Graph of the data from (A) 
plotted as the percentage of  
BODIPY-fluorescence intensity 
versus migration distance.  
Representative data of two 
independent experiments are 
shown. 
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2. The L. pneumophila Ran activator LegG1 modulates phagocyte 
chemotaxis 
Based on recent findings that the Icm/Dot translocated effector protein LegG1 acts as a 
bacterial activator of Ran and stabilizes microtubules 18, the effect of LegG1 on host cell 
migration was analyzed. 
To this end, D. discoideum cells were infected with L. pneumophila strains (MOI 10, 1 h) lacking 
LegG1 (ΔlegG1) or overexpressing LegG1 (ΔlegG1/+legG1). Results, represented in Figure 12A-B, 
revealed that the migration of D. discoideum cells infected with the wild-type strain was inhibited 
and even more following an infection with the ΔlegG1 strain. This hyper-inhibition phenotype 
was reverted by complementing LegG1 to a similar extent as observed for mutant bacteria 
lacking a functional Icm/Dot T4SS.  
Additionally, the same effect was observed using murine macrophages (Figure 12C and D) and 
freshly isolated human neutrophils (Figure 12E and F). Similar to amoebae, the L. pneumophila 
strain lacking LegG1 caused a hyper-inhibition of directed cell migration of these immune cells, 
which was complemented and reverted by inserting LegG1 on a plasmid.  
Furthermore, the influence of other L. pneumophila effectors was analyzed. Strains lacking the ER 
interactor SidC (Figure 13A), the Rab1 GEF SidM (Figure 13B) or the Icm/Dot component IcmG 
(alias DotF, Figure 13C) were used to test their effect on amoebae migration in comparison to 
LegG1. All mutants inhibited chemotaxis to a similar extent as the wild-type strain; ΔicmG only 
partially decreased migration. The phenotypes were reverted by providing the effector genes on 
plasmids.  
In summary, the absence of the Ran activator LegG1 specifically hyper-inhibits migration of cells 
infected with Icm/Dot-proficient L. pneumophila. The impairment of directed cell migration by 
strains lacking LegG1 was even more pronounced than after infection with wild-type bacteria. 
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Figure 12. The L. pneumophila Ran activator LegG1 modulates phagocyte migration. 
A. D. discoideum strain Ax3 harboring pSW102 (GFP) was infected for 1 h at an MOI of 10 with DsRed-
labelled L. pneumophila wild-type, ΔicmT, ΔlegG1 or ΔlegG1/+legG1 strains. Cell migration towards folic 
acid (1 mM) was followed for another 4 h in an under-agarose assay.  
B. Data from (A) were plotted as the percentage of GFP fluorescence intensity versus migration distance. 
C. Murine RAW 264.7 macrophages were infected (MOI 10, 1 h) with the same L. pneumophila strains as 
described in (A). Cells were stained with the CellTracker Green BODIPY and allowed to migrate towards 
CCL5 (100 ng mL
-1
) in an under-agarose assay for another 4 h.  
D. Graph of the data from (C) plotted as percent green fluorescence intensity versus migration distance. 
E. Freshly isolated human neutrophils were infected (MOI 10, 1 h) with L. pneumophila (wild-type, ΔicmT, 
ΔlegG1 or ΔlegG1/+legG1), stained with CellTracker BODIPY and migration towards fMLP (100 ng mL
-1
) 
was followed in an under-agarose assay for 4 h.  
F. Graph of the data from (E) plotted as the percentage of green fluorescence intensity versus migration 
distance. The white lines represent the boundary of the sample wells. The data shown are representative 
of at least three independent experiments.  
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To confirm that the effects of L. pneumophila on cell migration were not caused by trivial 
bacterial impacts, uptake efficiency or cytotoxicity of wild-type, ΔicmT, ΔlegG1 or ΔlegG1/legG1 
L. pneumophila strains were determined by flow cytometry or microscopy. The uptake efficiency 
(Figure 14A) of GFP-labelled bacteria by D. discoideum amoeba was comparable for all strains. 
The measured cytotoxicity (PI-positive cells) was in a low range (2-7%, Figure 14B). Thus, the 
L. pneumophila infection was not toxic for host cells. 
Furthermore, LCV formation (Figure 14C), morphology (Figure 14D) and transient polarization 
dynamics through the localization of PIP3 (Figure 14E) of D. discoideum cells were assayed by 
immunofluorescence. No significant differences were observed after an infection (MOI 10, 1 h) 
with the wild-type, ΔlegG1 or ΔlegG1/+legG1 strain. Likewise, no distinguishable alterations were 
observed for uptake efficiency and cytotoxicity of the L. pneumophila strains in infected murine 
macrophages or human neutrophils (Figure 15A-D).  
These data are in agreement with the notion that the inhibition of migration is governed by a 
specific Icm/Dot- dependent process. 
 
 
 
 
 
Figure 13. Effect of L. pneumophila effectors on D. discoideum migration.  
D. discoideum amoebae harboring pSW102 (GFP) were infected with L. pneumophila wild-type, ΔicmT, 
ΔsidC, ΔsidC/+M45-sidC (A), ΔsidM, ΔsidM/+sidM (B) or ΔicmG (C) for 1 h at an MOI of 10. Migration 
towards folic acid (1 mM) was monitored for 4 h. Graphs represent the data plotted as the percentage of 
GFP fluorescence intensity versus migration distance. Data are representative of at least two independent 
experiments. 
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Figure 14. Morphological and physiological features of infected amoebae. 
D. discoideum cells, grown in MB medium, were infected (MOI 10, 23 °C) with L. pneumophila             
wild-type, ΔicmT, ΔlegG1 or ΔlegG1/+legG1.  
A. Uptake efficiency was determined 1 h post-infection by flow cytometry or microscopy. 
B. Cytotoxicity was assessed by flow cytometry after infection (4 h) and subsequent PI staining 
(2.5 µg mL
-1
). 
C. LCV formation was determined by fluorescence microscopy using an anti-SidC antibody (n = 400 cells 
per strain).  
D. Morphology of amoebae cells producing GFP was analyzed by microscopy. 
E. Cell polarity was analyzed using the D. discoideum strain producing the PtdIns(3,4,5)P3 probe GFP-
PHCrac (PIP3). Data represent means and standard deviations of 3 (A, B) or 2 (D, E) independent 
experiments. Student´s t-test; ** p < 0.01, *** p < 0.001. 
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Figure 15. Uptake efficiency and cytotoxicity of L. pneumophila-infected macrophages and 
human neutrophils.  
A, C. Murine RAW 264.7 macrophages or human neutrophils were infected (MOI 10, 1 h) with GFP-
labelled L. pneumophila wild-type, ΔicmT, ΔlegG1 or ΔlegG1/+legG1. Uptake efficiency was determined 
as the percentage of GFP-positive cells.  
B, D. Cytotoxicity of L. pneumophila wild-type, ΔicmT, ΔlegG1 or ΔlegG1/+legG1 was analyzed after 4 h 
of infection by PI staining (2.5 µg mL
-1
) of the infected phagocytes (macrophages and neutrophils). Graphs 
indicate means and standard deviations of three independent experiments. 
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3. Single cell tracking of L. pneumophila-infected phagocytes 
The impacts of L. pneumophila and its effector LegG1 on phagocyte migration were 
analyzed in more detail. Cells were tracked on a single cell level using an under-agarose assay and 
appropriate tracking software. First, D. discoideum cells were infected (MOI 10, 1 h) with DsRed-
labelled L. pneumophila strains (wild-type, ΔicmT, ΔlegG1 or ΔlegG1/+legG1). Infected cells were 
tracked for 15 min within a 2 h window (Figure 16A), then forward migration index (FMI) and 
velocity were calculated. Compared to ΔicmT-infected cells, the FMI was reduced threefold for 
cells infected with L. pneumophila wild-type or ΔlegG1 mutant strain. The FMI of amoebae 
infected with the ΔlegG1/+legG1 strain was decreased twofold. Velocity was diminished twofold 
for wild-type, ΔlegG1 or ΔlegG1/+legG1- but not for ΔicmT-infected cells. No differences were 
observed between uninfected (data not shown) and ΔicmT-infected cells (Figure 16B). Small 
changes in FMI and velocity attributable to the absence or overexpression of LegG1 were not 
statistically significant.  
 
Figure 16. LegG1 affects forward migration and velocity of infected D. discoideum cells. 
A. D. discoideum Ax3 cells harboring pSW102 (GFP) were infected (MOI 10, 1 h) with DsRed-labelled 
L. pneumophila wild-type, ΔicmT, ΔlegG1 or ΔlegG1/+legG1. Infected cells were tracked in an under-
agarose assay towards folic acid for 15 min in a 2 h time window. The corresponding plots were 
established using the ImageJ manual tracker. 
B. The motility parameters FMI and velocity were analyzed using the Ibidi chemotaxis software. Student´s 
t-test; ** p < 0.01, *** p < 0.001. 
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Similar experiments were performed using murine RAW 264.7 macrophages and freshly isolated 
human neutrophils. After staining with CellTracker Green BODIPY, cells were tracked for 1 h at 2h 
post-infection in an under-agarose assay. Figure 17A and C show representative tracking plots of 
macrophages and neutrophils, respectively. Compared to ΔicmT-infected or uninfected cells 
(data not shown), the FMI for macrophages (Figure 17B) and neutrophils (Figure 17D) infected 
with wild-type bacteria or lacking the protein LegG1 was reduced by half. Again, no differences 
were observed between uninfected cells or cells lacking a functional Icm/Dot secretion 
system (ΔicmT).  
Contrary to D. discoideum amoebae, both the FMI and the velocity of macrophages (Figure 17B) 
and neutrophils (Figure 17D) infected with the complementation strain of L. pneumophila 
(ΔlegG1/+legG1) were significantly increased. The speed of wild-type or ΔlegG1-infected immune 
cells was similarly decreased (1.25 fold) when compared to ΔicmT-infected cells, although to a 
lesser degree as D. discoideum cells. 
These findings suggest that the L. pneumophila effector LegG1 affects directionality and speed of 
infected amoebae and leukocytes, thereby modulating chemotaxis and migration of infected 
cells. 
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Figure 17. LegG1 alters motility parameters of infected immune cells. 
A, C. Murine RAW 264.7 macrophages or human neutrophils were stained with CellTracker Green 
BODIPY and infected with DsRed-labelled L. pneumophila (MOI 10, 1 h) wild-type, ΔicmT, ΔlegG1 
harboring or ΔlegG1/+legG1. Macrophages or neutrophils motility towards CCL5 (100 ng mL
-1
) or fMLP 
(100 ng L
-1
), respectively, was tracked in an under-agarose assay for 1 h. The corresponding plots were 
made using the ImageJ manual tracker. 
B. The motility parameters FMI and velocity were determined using the Ibidi chemotaxis software. 
Student´s t-test; ** p < 0.01, *** p < 0.001. 
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4. L. pneumophila LegG1 promotes random cell migration dependent on 
the small GTPase Ran 
Having determined that L. pneumophila affects directed migration, the effect of 
L. pneumophila wild-type, ΔicmT, ΔlegG1 and ΔlegG1/+legG1 on random cell migration was 
examined. For this purpose, the scratch assay, also known as wound-healing assay, was used. 
Confluent cell layers were scratched and monitored over 24 h after bacterial infection.  In order 
to underpin earlier results, layers of murine macrophages were infected (MOI 10, 1 h) with the 
L. pneumophila strains listed above. Images of the scratched positions were taken 0 h and 24 h 
after infection (Figure 18A). After 24 h, the scratch of wild-type or ΔlegG1-infected cells was 
closed to 25% whereas no wound (100% scratch closure) was left for uninfected cells or cells 
infected with ΔicmT or ΔlegG1/+legG1 mutant bacteria (Figure 18B).  
Since LegG1 is an activator of the Ran GTPase, the role of Ran on LegG1-dependent modulation 
of cell migration was analyzed. To this end, a scratch assay was performed using epithelial A549 
cells pretreated for 48 h with small interfering (siRNA) to knockdown Ran. Cells were then 
infected with L. pneumophila wild-type, ΔicmT, ΔlegG1 or ΔlegG1/+legG1. Cells (mock or 
scrambled) treated only with transfection reagent or negative siRNAs served as controls. Images 
of the scratched positions were taken 0 h  and 24 h after the infection (Figure 18C). The scratch 
was closed to a similar extent for untreated (no bacterial infection or siRNA treatment), ΔicmT or 
ΔlegG1/+legG1-infected epithelial cells (100% closure) and for wild-type or ΔlegG1-infected cells 
(approximately 30% closure). Upon siRNA treatment, the scratch closure was comparable to 
control cells, for each condition, except for cells infected with the complementation strain of 
LegG1 (ΔlegG1/+legG1). The scratch closure was approximately 30% as observed for cells 
infected with L. pneumophila wild-type or ΔlegG1 (Figure 18D). This result suggests that LegG1 
requires Ran to exhibit its effect. Efficiency of Ran depletion was controlled by Western Blot (data 
not shown). 
Furthermore, in a similar approach, confluent cell layers of HeLa cells were subjected to 
„microbial microinjection” with LegG1. The effect of a single effector protein on host cell 
migration could be performed using Yersinia enterocolitica strains WA (pT3SS) lacking 
endogenous effectors but producing YopE1-53, YopE1-53-LegG1, YopE1-138 or YopE1-138-LegG1.  
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The N-terminal fragments of YopE are not cytotoxic and allow the secretion and translocation of 
hybrid proteins through the T3SS. Following cell contact, these Y. enterocolitica strains directly 
inject LegG1 into the host cell and promote microtubule polymerization 18. The confluent cell 
layers were infected (MOI 10, 90 min) and scratched. Images were taken 0 h and 24 h after 
infection (Figure 18E). As expected, the N-terminal fragments YopE1-53 and YopE1-138 did not 
promote random cell migration as indicated by the scratch closure being below 25%. HeLa cells 
infected with Yersinia strains producing YopE-LegG1 fusion proteins migrated and significantly 
reduced the wound over time. The scratch closure was between 80 – 100% similar to uninfected 
cells (Figure 18F).  
Taken together, these results suggest that the positive effect of LegG1 on random cell migration 
is dependent on Ran. Additionally, the bacterial effector is required and sufficient to promote cell 
motility of macrophages and epithelial cells. 
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Figure 18. L. pneumophila LegG1 promotes random cell migration dependent on the small 
GTPase Ran. 
A. Confluent cell layers of murine RAW 264.7 macrophages were infected (MOI 10, 90 min) with DsRed-
labelled L. pneumophila wild-type, ΔicmT, ΔlegG1 or ΔlegG1/+legG1, washed and scratched with a sterile 
pipette tip. Detached cells were washed away and images of the scratched positions taken 0 h and 24 h 
after infection.  
B. The remaining scratch area (scratch closure) was quantified using the ImageJ software. 
C. Confluent layers of A549 cells were treated with RNA interference (siRNA) against Ran for 48 h, 
infected (MOI 10, 90 min) and scratched as described in (A). Images of the scratched positions were 
taken after 0 h and 24 h. 
D. Quantification of the scratch closure was performed using the ImageJ software. 
E. HeLa cells were seeded and infected (MOI 10, 90 min) with Y. enterocolitica strains producing     
YopE1-53, YopE1-53-LegG1, YopE1-138 or YopE1-138-LegG1. Scratches and images were made as 
described in (A-C).  
F. Quantification of the remaining scratch area was achieved using the ImageJ software. Student´s t-test; 
** p < 0.01, *** p < 0.001. 
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5. Real-time analysis of LegG1-dependent cell motility and microtubule 
polymerization 
To address the question, whether LegG1 affects cell motility and subsequent microtubule 
dynamics, a real-time study was performed. D. discoideum cells producing GFP-α-tubulin were 
infected with L. pneumophila wild-type, ΔlegG1 or the complementation strain ΔlegG1/+legG1. 
Cells showed a strongly impaired motility and microtubule polymerization after an infection with 
the ΔlegG1 mutant strain when compared to L. pneumophila wild-type. This effect could be 
complemented by providing the legG1 gene on a plasmid (Figure 19). These observations are in 
agreement with those made by Rothmeier et al., where the motility of LCVs harboring ΔlegG1 
was found to be abolished 18. These results indicate that LegG1 specifically promotes 
microtubule-dependent cell motility.  
 Figure 19. The Ran 
activator LegG1 promotes 
microtubule dynamics and 
cell motility. 
Microtubule dynamics and 
cell motility of D. discoideum 
producing GFP-α-tubulin 
were observed in real-time 
fluorescence microscopy. 
Cells were infected (MOI 10, 
2 h) with DsRed-labelled 
L. pneumophila wild-type, 
ΔlegG1 or ΔlegG1/+legG1. 
After 2 h of infection, 
microtubule polymerization 
was recorded using 
confocal microscopy. Images 
were taken every 15 sec.  
 
In summary, the results of this first section demonstrate that L. pneumophila inhibits phagocyte 
migration in an Icm/Dot-dependent manner. Using several migration assays and host cells, it was 
shown that the bacterial effector LegG1 and consequent microtubule polymerization antagonizes 
the migration inhibition caused by L. pneumophila. 
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B. The L. pneumophila quorum sensing molecule LAI-1 modulates host 
cell migration through an IQGAP1-Cdc42-dependent pathway 
QS molecules allow the bacteria to perform cell-cell communication, not only amongst 
each other, but also with their hosts in a process known as inter-kingdom signaling. In 
L. pneumophila, the autoinducer LAI-1 (3-hydroxypentadecane-4-one) is produced by the 
synthase LqsA, sensed and regulated by LqsS and LqsR, respectively. A novel sensor kinase 
termed LqsT was recently discovered 105. Among others, studies on P. aeruginosa 102 describing 
the modulation of host cell migration by QS molecules led us to study the effect of LAI-1 on cell 
motility and analysis of downstream effects.  
 
1. Quorum sensing regulators and the autoinducer molecule LAI-1      
dose-dependently affect host cell migration and chemotaxis 
In a first attempt to identify possible effects of QS regulators on host cells, the influence 
of five lqs mutant strains (ΔlqsS, ΔlqsT, ΔlqsS-lqsT, ΔlqsR or ΔlqsA) on cell motility and chemotaxis 
was assessed. To this end, D. discoideum amoebae were infected for 1 h at an MOI of 10 with 
these different strains and allowed to migrate in an under-agarose assay towards folic acid 
(Figure 20A). After 4 h, the migration distance was determined. The migration pattern of cells 
infected with ΔlqsR or ΔlqsA mutant strains was similar to uninfected cells and to cells infected 
with the ΔicmT strain, reaching a distance of approximately 1000 µm. An inhibition of migration 
was visible for the ΔlqsS, ΔlqsT or ΔlqsS-lqsT strains similar to L. pneumophila wild-type        
(Figure 20B).  
In a further experiment, murine macrophages (Figure 20C) were infected with the strains listed 
above. After 4 h of chemotaxis towards CCL5, only the ΔlqsA strain did not affect macrophage 
chemotaxis. The migration distance reached 500 µm, similar to uninfected or cells infected with 
the ΔicmT mutant strain. In contrast, the motility of cells infected with the ΔlqsS, ΔlqsT, ΔlqsS-lqsT 
or ΔlqsR strains was almost completely abolished.  
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Figure 20. Effect of QS regulators on host cell chemotaxis. 
A. D. discoideum cells harboring Ax3 pSW102 (GFP) were infected (MOI 10, 1 h) with L. pneumophila 
wild-type, ΔicmT, ΔlqsS, ΔlqsT, ΔlqsS-lqsT, ΔlqsR or ΔlqsA mutant strains. Directed migration towards 
folic acid (1 mM) was monitored for 4 h in an under-agarose assay. The white lines represent the edge of 
the well. 
B. Graph represents the data from (A) plotted as the percentage of GFP fluorescence intensity versus 
migration distance. 
C. Graph depicts the migration of infected macrophages (same strains and conditions as mentioned in 
(A)). Cells were stained with a CellTracker Green BODIPY and allowed to migrate towards CCL5 
(100 ng mL
-1
) for 4 h. The percentage of GFP fluorescence intensity versus migration distance is 
visualized. The data shown are representative of at least three independent experiments. 
 
As there was no inhibition of migration observed for cells infected with the L. pneumophila strain 
lacking the autoinducer LqsA, responsible for the production of LAI-1, a closer look on the effect 
of LAI-1 on host cell motility was taken. 
The influence of different concentrations of racemic LAI-1 (0.5 – 10 µM) was analyzed in a 
chemotactic under-agarose assay. After LAI-1 treatment, D. discoideum amoebae migrated for 
4 h towards folic acid (Figure 21A). A dose-dependent inhibition of directed cell migration was 
revealed with a strong negative effect above a concentration of 3 µM (migration distance of 
approximately 750 µm instead of 1200 µm for untreated cells). A complete inhibition was 
observed upon treatment with 10 µM LAI-1.  
Likewise, to test which enantiomer of LAI-1 or its amino-derivate is biologically more active, the 
impact of (R)- and (R)-Am- or (S)- and (S)-Am-LAI-1 was tested in the migration assay. The 
directed movement of D. discoideum cells was distinctly inhibited by the (R)-form; approximately 
750 µm of migration distance compared to 1200 µm for amoebae treated with the (S)-form 
(Figure 21B).  
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Additionally, the autoinducer molecule CAI-1 of V. cholerae was tested at different 
concentrations and resulted in a similiar dose-dependent inhibition of D. discoideum chemotaxis 
(Figure 21C). The effect was evident at a concentration of 3 µM (migration distance of 1000 µm) 
and most pronounced at 10 µM (600 µm). However, migration was never completely inhibited. 
 
 
 
Figure 21. Dose-dependent inhibition of cell migration by LAI-1. 
Migration of D. discoideum amoebae Ax3 harboring pSW102 (GFP) towards folic acid (1 mM) was 
followed in an under-agarose assay for 4 h. Cells were treated with racemic LAI-1 (0,5 – 10 µM. (A)),        
(R)-LAI-1, (S)-LAI-1, (R)-Am-LAI-1 or (S)-Am-LAI-1 (10 µM, B) or with different concentrations of CAI-1       
(0,5 – 10 µM, (C)) for 1 h. Graphs represent the percentage of fluorescence intensity versus migration 
distance. The results are representative of at least three independent experiments. 
 
In order to rule out that the addition of LAI-1 is toxic for cells and therefore causing the observed 
effect, cytotoxicity of different concentrations of LAI-1 (1, 5 or 10 µM) in combination with 
L. pneumophila infection (wild-type or ΔicmT, MOI 10 for 1 h) was evaluated. To this end, cells 
were stained with PI and analyzed by flow cytometry. The data showed that neither LAI-1 nor 
L. pneumophila infection dramatically influenced the survival of D. discoideum amoebae or 
murine RAW 264.7 macrophages (Figure 22A and B, respectively). The percentage of PI-positive 
cells was similar with or without LAI-1 and/or in presence of bacteria; approximately 10% for 
D. discoideum and 30% for macrophages. 
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Figure 22. LAI-1 is not toxic for cells. 
D. discoideum cells (A) and murine RAW 264.7 macrophages (B) were infected (MOI 10) with 
L. pneumophila wild-type or ΔicmT and treated with LAI-1 (1, 5 and 10 µM) for 4 h. Cytotoxicity was 
determined by flow cytometry following PI staining (2.5 µg mL
-1
). The percentage of PI positive cells is 
depicted. 
 
Since LAI-1 negatively influences cell migration, the next aim was to analyze the motility 
parameters FMI and velocity.  First, D. discoideum cells, untreated or treated with DMSO or LAI-1 
(10 µM), were tracked at a single cell level using a chemotactic migration assay (Figure 23A). The 
FMI and the velocity were determined (Figure 23B). The addition of LAI-1 significantly reduced 
the FMI by half but not the velocity, compared to untreated control cells.  
A dose-dependent inhibition of murine macrophage migration by LAI-1 was observed          
(Figure 23C). Therefore, the cells were subsequently used to gain insights into the cellular impact 
of LAI-1. A closer look revealed that LAI-1 causes microtubule depolymerization (Figure 23D) and 
dramatic actin destabilization (Figure 23E). The number of microtubule fibers per cell was 
strongly reduced; from 8 in control cells to about 3 in LAI-1-treated cells. Nocodazole, a 
microtubule destabilizing compound, was used as a negative control (data not shown). 
Furthermore, cortical actin was significantly damaged. Over 80% of untreated control cells 
possess intact actin compared to only 10% of LAI-1-treated cells. 
Taken together, these results provided initial insights into the intracellular effect of LAI-1. A dose-
dependent inhibition of chemotaxis and reduction in the forward migration of the cell was 
revealed. Additionally, the impact of LAI-1 was attributable to a direct alteration of the 
microtubule and actin cytoskeleton. 
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Figure 23. LAI-1 negatively alters directed cell migration by influencing microtubule and actin 
polymerization. 
A. D. discoideum Ax3 strain harboring pSW102 (GFP) was treated with LAI-1 (10 µM) for 2 h. Single cell 
migration towards folic acid (1 mM) was tracked in an under-agarose assay for 15 min. Plots are 
representative of at least three independent experiments with 15 – 20 cells tracked per experiment. 
B. FMI and velocity were analyzed using the ImageJ manual tracker and Ibidi chemotaxis software. 
C. Murine RAW 264.7 macrophages were treated with different concentrations of racemic LAI-1 (1, 5 or 
10 µM) and chemotaxis towards CCL5 (100 ng mL
-1
) was documented after 4 h in an under-agarose 
assay by staining cells with a Cell Tracker Green BODIPY. Graph depicts the percentage of fluorescence 
intensity versus the migration distance and is representative of at least three independent experiments. 
D. Murine RAW 264.7 macrophages were treated with LAI-1 (10 µM, 1 h) and immuno-labeled with        
-tubulin (green). Microtubule polymerization was analyzed using confocal fluorescence microscopy by 
counting the number of microtubules fibers per cell along a cross-section.  
E. The effect of LAI-1 (10 µM, 1 h) on actin (phalloidin, red) polymerization in RAW 264.7 macrophages 
was determined by quantifying the number of cells with cortical actin.  
Graphs show means and standard deviations of three independent experiments (n > 25 single cells for 
one experiment). Student´s t-test; * p < 0.05, ** p < 0.01. 
 
 
 
 
 
    Results 
67 
 
2. LAI-1-dependent inhibition of cell migration requires IQGAP1 and Cdc42 
Possible factors implicated in the LAI-1-triggered host cell signaling pathways were 
investigated. For this purpose, the effect of LAI-1 on random cell migration was assessed in a 
scratch/wound healing assay. A549 epithelial cells were used because of their sensitivity to RNA 
interference (siRNA) treatment, thus allowing the identification of host factors crucial for cell 
migration.  
Confluent layers of A549 cells were treated for 48 h with siRNA against IQGAP1 or the small 
GTPases Cdc42, RhoA or Rac1 and with LAI-1 (10 µM). After treatment, images of the scratched 
positions were taken at time points 0 h and 24 h (Figure 24A). The percentage of scratch closures 
after 24 h is shown in Figure 24B.  
Cells treated with LAI-1 alone did not close the scratch in comparison to the scrambled control 
(100% compared to 25%). For cells treated with siRNA only, the scratches were more or less 
closed after 24 h. Approximately 80%, 75%, 50% and 80% scratch closure was observed for 
IQGAP1, Cdc42, RhoA and Rac1, respectively. Upon depletion of IQGAP1, Cdc42 or RhoA and 
treatment with LAI-1, the scratch closures were about 90%, 80% or 50%, respectively. This was 
not the case for Rac1, where the scratch remained open (closure below 25%). Since the depletion 
of Rac1 did not affect the inhibition of random cell migration by LAI-1, this small GTPase is 
dispensable for LAI-1 signaling. Of note, there was no distinguishable difference in the closure of 
cells treated with siRNA against RhoA, with or without LAI-1. For both conditions, the scratches 
were closed to 50%, suggesting that the depletion of RhoA alone reduces random cell migration 
to some extent. The siRNA depletion efficiencies were determined by Western Blot (Figure 24C). 
In summary, these experiments revealed that transduction of LAI-1-mediated inter-kingdom 
signaling is significantly and specifically promoted by IQGAP1 and Cdc42. 
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Figure 24. LAI-1-dependent inhibition of cell migration requires IQGAP1 and Cdc42. 
A. Confluent layers of A549 epithelial cells were treated for 48 h with siRNA against IQGAP1, Cdc42, 
RhoA or Rac1. Cells treated only with transfection reagent (mock), LAI-1 (10 µM) or transfected with 
negative nonsense oligonucleotides (scrambled siRNA) served as controls. The epithelial cells were then 
treated with LAI-1 (10 µM, 90 min), scratched with a sterile pipette tip and allowed to migrate for another 
24 h. After washing detached cells off, images of the scratched position were taken at time point 0 h and 
after 24 h using confocal microscopy. 
B. After 24 h, the percentage of scratch closure was quantified using the ImageJ software. Means and 
standard deviations from at least three independent experiments are represented (comparison between 
untreated cells and the corresponding LAI-1 condition).  
C. A549 cells were treated with the mentioned siRNA for 48 h and the samples were harvested and 
prepared for SDS-PAGE. The siRNA efficiency was controlled by Western Blot using the corresponding 
antibody for each protein. Untreated, mock and scrambled samples served as controls for the siRNA 
treated sample (O1-4). GAPDH (36 kDa) was used as a positive control. Student´s t-test; ** p < 0.01. 
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3. LAI-1 triggers inactivation of Cdc42 and redistribution of IQGAP1 
To determine whether LAI-1 has an impact on the activation of Cdc42, pulldown 
experiments using A549 epithelial cells treated with LAI-1 (10 µM) and subsequent anti-Cdc42 
Western blotting were performed (Figure 25A).  
The amount of active Cdc42 was determined using an antibody directed against Cdc42(GTP) and 
band intensities were quantified by densitometry (Figure 25B). An antibody recognizing both the 
inactive (GDP) and active (GTP) forms of Cdc42 was used to control the efficiency of the 
pulldown. An anti-GAPDH control was employed to ensure that an equal amount of protein was 
present. This examination showed that LAI-1 reduced the amount of active Cdc42(GFP) 
approximately fourfold. The quantity of Cdc42(GTP/GDP) was unchanged after LAI-1 treatment in 
comparison to untreated control cells. 
 
 
 
Figure 25. LAI-1 promotes the inactivation of Cdc42. 
A. A549 epithelial cells treated with LAI-1 (10 µM, 1 h) were used for pulldown assays and a subsequent 
Western Blot. The activation state of Cdc42 (21 kDa) was analyzed using antibodies recognizing 
Cdc42(GTP/GDP) or Cdc42(GTP) only. GAPDH (36 kDa) served as loading control. 
B. Graph represents the quantification by densitometry using the ImageJ software (Student´s t-test; 
** p < 0.01). 
 
Further, the localization of IQGAP1 and Cdc42 in the cell after LAI-1 treatment was studied. A549 
cells were incubated with the L. pneumophila QS molecule LAI-1 (10 µM, 1 h) and immuno-
stained against IQGAP1 (Figure 26A) or Cdc42 (Figure 26C).  
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Upon addition of LAI-1, a clear relocalization to the cellular cortex was observed for IQGAP1, but 
not for Cdc42. Quantifications of this redistribution are represented in Figure 26B for IQGAP1 and 
in Figure 26D for Cdc42. After LAI-1 treatment, nearly 100% of the cells exhibited a relocalization 
of IQGAP1 from the cytoplasm to the cell cortex. In contrast, the cytoplasmic localization of 
Cdc42 remained unchanged after LAI-1 addition.  
Furthermore, a possible impact of LAI-1 on the phosphorylation status of Cdc42 was assessed by 
staining A549 cells treated with LAI-1 (10 µM) with an antibody recognizing Cdc42/Rac1-
phospho-Ser71. However, no changes were observed in the phosphorylation by fluorescence 
microscopy (Figure 26E and 26F). 
In summary, a LAI-1-dependent inactivation of the GTPase Cdc42 and redistribution of IQGAP1 to 
the cellular cortex were demonstrated. 
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Figure 26. LAI-1 causes a 
redistribution of IQGAP1 to 
the cellular cortex.  
A549 cells were treated with 
LAI-1 (10 µM, 1 h), fixed and 
stained with antibodies (FITC, 
green) against IQGAP1 (A) or 
Cdc42 (C). Nuclei were 
stained with DAPI in blue. 
Protein localization was 
analyzed by confocal 
fluorescence microscopy. 
Graphs depict the relative 
fluorescence intensity along a 
section of a cell (arbitrary 
units, AU) and the 
quantification of protein 
relocalization (B, IQGAP1; D, 
Cdc42). Redistribution of 
IQGAP1 was observed in over 
50 cells per condition after 
LAI-1 treatment.  
A549 cells were stained with 
an antibody against 
Cdc42/Rac1-phospho-Ser71 
(FITC, green) and analyzed 
by confocal fluorescence 
microscopy (E). Graph (F) 
illustrates, through the relative 
fluorescence intensity along a 
section of a cell (arbitrary 
units, AU), no difference in the 
phosphorylation status of 
Cdc42 after LAI-1 treatment 
(10 µM, 90 min). Student´s     
t- test; *** p < 0.001. 
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4. Inhibition of cell migration through LAI-1 requires the Cdc42 
GEF ARHGEF9 
As LAI-1 causes an inactivation of Cdc42, the activation mechanism of the small GTPase 
was further investigated. The activation status of Cdc42 is controlled by GEFs or GAPs which 
appeared to be the next plausible targets to test. Three GEFs (ARHGEF9, FGD1 or DOCK11) and 
two GAPs (GAP1 or GAP17), specific for Cdc42, were depleted by RNAi in epithelial A549 cells. To 
test whether these regulators are involved in LAI-1 signaling, a scratch assay was performed.  
Confluent cell layers were treated with siRNA against the GEFs and GAPs for 48 h and/or with   
LAI-1 (10 µM, 90 min). Images of the scratched positions were taken at time points 0 h and 24 h 
after treatment (Figure 27A) and the scratch closure was evaluated after 24 h of random 
migration (Figure 27B). The scratches remained open for all cells treated with LAI-1 and depleted 
for FGD1, DOCK11, GAP1 or GAP17 (around 15-20%), but not GEF9 (closure nearly 100%). 
Therefore, GEF9 is required for LAI-1-dependent signaling of cell migration inhibition. The scratch 
closure was approximately 100% for control cells (treated with siRNA only). The siRNA efficiency 
was controlled by Western Blot using the corresponding antibodies for each protein (Figure 27C).  
These results implicate that only GEF9 is involved in the activation/inactivation of Cdc42 by LAI-1 
as the depletion of this GTPase abrogated the effect of LAI-1. 
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Figure 27. Cell migration inhibition through LAI-1 requires the Cdc42 GEF9. 
A. Confluent layers of A549 cells were treated with siRNA against Cdc42 GEFs (GEF9, FGD1 or 
DOCK11) or GAPs (GAP1 or GAP17) for 48 h. Cells were additionally treated with LAI-1 (10 µM, 90 min), 
scratched with a sterile pipette tip and allowed to migrate for another 24 h. Closure of the wound was 
visualized at time point 0 h and after 24 h. 
B. After 24 h, the scratch closure was quantified using the ImageJ software. Means and standard 
deviations are representative of three independent experiments.  
C. The siRNA treatment efficiency was controlled by Western Blot for GEF9 (61 kDa) and GAP17 
(95 kDa). GAPDH (36 kDa) served as a loading control. Means and standard deviations of three 
independent experiments are depicted. Student´s t-test; *** p < 0.001. 
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5. IQGAP1 functions upstream of Cdc42 in the LAI-1 signaling pathway 
In order to test whether IQGAP1 is functioning upstream or downstream of Cdc42, A549 
epithelial cells were treated with siRNA against IQGAP1 or Cdc42, with or without LAI-1 and 
immuno-stained for IQGAP1 or Cdc42. The cellular localization of these proteins was determined 
by fluorescence microscopy (Figure 28A).  
IQGAP1 and Cdc42 were visible in the cytoplasm of control cells (untreated, mock or scrambled). 
In cells treated with siRNA against IQGAP1 (depletion efficiency 100%), Cdc42 was barely 
produced with only 10% of the protein remaining. In cells treated with siRNA against Cdc42, 
IQGAP1 was present at almost 100%. The depletion of target proteins was efficient with nearly 
no proteins being detectable for both conditions (Figure 28B).  
A combination of siRNA treatment against Cdc42 and exposure to LAI-1 (10 µM) revealed that 
IQGAP1 was still present in cells and redistributed to the cell cortex (Figure 28C).  
Taken together, this experiment showed that the scaffold protein IQGAP1 functions upstream of 
Cdc42 and regulates the stability of the small GTPase. Furthermore, the relocalization of IQGAP1 
in the LAI-1 signaling cascade is not dependent on Cdc42. 
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Figure 28. IQGAP1 
functions upstream of 
Cdc42 in the LAI-1 
signaling cascade. 
A. A549 cells were treated 
with LAI-1 (10 µM, 1 h) 
and/or with siRNA against 
IQGAP1 and Cdc42 for 48 h, 
fixed and stained with 
antibodies against IQGAP1 
(FITC, green) or Cdc42 
(Cy5, red). Protein 
localization was visualized 
by confocal fluorescence 
microscopy. Nuclei were 
stained with DAPI in blue. 
B. Graph represents the 
quantification of proteins 
present (IQGAP1 or Cdc42) 
after siRNA treatment 
(IQGAP1 or Cdc42). 
C. Graph shows the 
quantification of IQGAP1- 
redistribution after the 
depletion of Cdc42 by 
siRNA.  
The protein localization was 
determined using the relative 
fluorescence intensity 
(arbitrary units, AU) along a 
section of a cell (n > 50). 
Means and standard 
deviations of three inde-
pendent experiments are 
shown. Student´s t-test; 
*** p < 0.001. 
 
    Results 
78 
 
6. LAI-1 reverses the Icm/Dot-dependent inhibition of migration 
caused by L. pneumophila 
L. pneumophila inhibits random and directed cell migration in an Icm/Dot-dependent 
manner (section A.1. and A.4.). As the bacterial autoinducer molecule LAI-1 negatively alters cell 
migration, the effect of L. pneumophila in combination with LAI-1 treatment was analyzed. To 
this end, different concentrations of LAI-1 (1, 5 or 10 µM) were added to D. discoideum  or 
macrophages infected (MOI 10, 1 h) with L. pneumophila wild-type (Figure 29A and 29C) or 
ΔicmT  (Figure 29B and Figure 29D). A chemotactic under-agarose assay was used to assess the 
migration of D. discoideum cells or macrophages towards folic acid (1 mM) or CCL5 (100 ng mL-1), 
respectively. A dose-dependent reversal of the inhibition caused by LAI-1 was observed upon 
infection with L. pneumophila wild-type in both cell types. Cells infected with the wild-type strain 
did not migrate, whereas a maximum migration distance of 1300 µm or 500 µm for D. discoideum 
cells or macrophages, respectively, was reached after LAI-1 treatment. Furthermore, LAI-1 
inhibited directed migration of ΔicmT-infected cells, as indicated by 600 µm instead of 1200 µm 
migration distance for D. discoideum cells or nearly zero instead of 500 µm for macrophages. 
Since the combination of bacteria and LAI-1 clearly reverses the previously described effects 
(section A.), a closer look on motility parameters was taken. D. discoideum cells were tracked 
(Figure 29E) after an infection and treatment with LAI-1 (10 µM). The FMI and velocity were 
investigated (Figure 29F). The FMI of cells infected with wild-type L. pneumophila was low 
(around 0.25) and high (0.65) for ΔicmT-infected cells similar to uninfected cells (data not 
shown). After LAI-1 treatment, the phenotypes were reversed. FMIs of nearly 0.6 and 0.35 were 
observed for wild-type- and ΔicmT-infected D. discoideum cells, respectively. No distinguishable 
differences were detected for the velocity with a value of approximately 0.3 µm sec-1 for each 
condition.  
These results suggest that L. pneumophila and LAI-1 target at least partly shared signaling 
pathways involved in chemotactic and random host cell migration. 
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Figure 29. LAI-1 reverses the Icm/Dot-dependent inhibition of migration caused by 
L. pneumophila. 
The effect of different concentrations of LAI-1 (1, 5 or 10 µM) on D. discoideum chemotaxis after infection 
(MOI 10, 1 h) with L. pneumophila wild-type (A) or an ΔicmT (B) strain was analyzed in an under-agarose 
assay. Amoebae harboring pSW102 (GFP) migrated for 4 h towards folic acid (1 mM) and were 
visualized by confocal fluorescence microscopy. Graphs show the percentage of fluorescence intensity 
versus migration distance and are representative of at least three independent experiments. 
Directed migration of RAW 264.7 macrophages towards CCL5 (100 ng mL
-1
) after L. pneumophila wild-
type (C) or ΔicmT (D) infection and LAI-1 treatment was monitored in an under-agarose assay for 4 h. 
Graph depicts the percentage of fluorescence intensity of macrophages, stained with a Green 
CellTracker BODIPY, versus their migration distance. Results are representative of at least three 
independent experiments. 
D. discoideum Ax3 strain harboring pSW102 (GFP) was infected (MOI 10, 1 h) with L. pneumophila wild-
type or ΔicmT mutant and treated with LAI-1 (10 µM, 1 h). Cells were tracked (n > 50) in an under-
agarose assay towards folic acid (1 mM) for 15 min. Tracking plots are representative of at least three 
independent experiments (E). Motility parameters (FMI and velocity) were analyzed using the ImageJ 
manuel tracker and the Ibidi chemotaxis software (F). Student´s t-test; * p < 0.05 ** p < 0.01. 
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7. Absence of Cdc42 promotes migration inhibition by L. pneumophila 
A possible hypothesis was that LAI-1 and L. pneumophila converge on common pathways 
or host factors to inhibit cell migration. For this purpose, confluent layers of A549 cells were first 
treated with siRNA against the small GTPases Cdc42 or Rac1 (as negative control) for 48 h and 
then infected with L. pneumophila wild-type or a ΔicmT mutant strain at an MOI of 10 for 90 min. 
Random migration was analyzed in a scratch assay and images were taken at time points 0 h and 
24 h after infection (Figure 30A). The percentage of scratch closure at the end time point is 
represented in Figure 30B. The scratches of control cells (scrambled or siRNA against Cdc42 or 
Rac1 only) and ΔicmT-infected cells treated or not with siRNA against Cdc42 or Rac1 were closed 
to 100% after 24 h. Cells infected with L. pneumophila wild-type, treated or not with siRNA 
against Rac1, did not close the scratch (nearly 0%). However, following depletion of Cdc42 and 
L. pneumophila wild-type infection, the failure of closing the scratch was quite dramatic. The 
scratch was more open than at time point 0 h reaching a closure value of - 80%.  Importantly, no 
increased cytotoxicity was observed under these conditions as cell morphology was unchanged. 
Moreover, the inhibition of random migration by wild-type L. pneumophila was severely and 
significantly augmented, in comparison to cells treated with siRNA against Cdc42 and infected or 
not with the ΔicmT mutant strain.  
 
Figure 30. Absence of Cdc42 
promotes the inhibition of 
migration by L. pneumophila. 
A. Confluent layers of A549 
cells were treated with siRNA 
against Cdc42 or Rac1 
(negative control) for 48 h and 
subsequently infected (MOI 10, 
90 min) with L. pneumophila 
wild-type or ΔicmT. Cells were 
scratched and allowed to 
migrate for another 24 h.  
B. After 24 h of migration, the 
percentage of scratch closure 
was determined using the 
ImageJ software. Means and 
standard deviations of three 
independent experiments are 
shown (Student´s t-test; 
*** p < 0.001). 
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Since the Icm/Dot-dependent inhibition of migration by L. pneumophila involves Cdc42, a closer 
look was taken regarding the cellular localization of the bacteria and the small GTPase. A549 
epithelial cells were infected (MOI 10, 1 h) with DsRed-labelled L. pneumophila wild-type or a 
ΔicmT mutant strain and treated or not with LAI-1 (10 µM, 1 h). The proteins of interest, IQGAP1 
(Figure 31A) and Cdc42 (Figure 31B), were stained with the corresponding antibody and the 
localization was analyzed by fluorescence microscopy. IQGAP1 as well as Cdc42 colocalized with 
the bacteria, yet the localization of either protein remained unchanged after LAI-1 addition.  
 
 
 
 
Figure 31. IQGAP1 and Cdc42 colocalize with L. pneumophila. 
A549 cells were infected (MOI 10, 1 h) with L. pneumophila wild-type or a ΔicmT mutant strain and 
treated with LAI-1 (10 µM, 1 h). Cells were fixed, stained with antibodies against IQGAP1 (A) or Cdc42 
(B) and analyzed by confocal fluorescence microscopy (IQGAP1 and Cdc42: FITC, green; nucleus: 
DAPI, blue; L. pneumophila: pSW102, red). 
 
Taken together, these results showed that the absence of the small GTPase Cdc42 promoted 
migration inhibition by L. pneumophila. Interestingly, a LAI-1-independent colocalization of 
IQGAP1 or Cdc42 with the bacteria was observed. 
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8. IQGAP1, Cdc42 and LAI-1 do not affect uptake and intracellular 
replication of L. pneumophila 
To exclude the possibility that the effects observed were caused by an interference 
between infection and siRNA treatment, intracellular replication assays were performed     
(Figure 32A). A549 cells were infected with L. pneumophila wild-type or ΔicmT mutant strains and 
treated with siRNA against IQGAP1 or Cdc42. Bacterial replication was followed over time (1, 20, 
24 and 48 h). After 24 h, the number of wild-type L. pneumophila increased while the ΔicmT 
strain did not replicate over 48 h. Therefore, the treatment with siRNA had no effect on 
intracellular replication of either strain. 
Moreover, the effect of different LAI-1 concentrations (1, 5 and 10 µM) on bacterial uptake 
efficiency was analyzed by flow cytometry. D. discoideum cells (Figure 32B) or murine 
macrophages (Figure 32C) were infected (MOI 10, 1 h) with L. pneumophilla wild-type or ΔicmT 
and treated with LAI-1 for 1 h. The addition of the autoinducer molecule did not significantly alter 
bacterial uptake of wild-type (more efficient than the mutant strain) or ΔicmT, either by 
D. discoideum or by macrophages. 
 
 
 
 
Figure 32. Intracellular replication or bacterial uptake is not affected by siRNA or LAI-1 
treatment, respectively. 
A549 cells were treated with a mixture of four oligonucleotides for each target (IQGAP1 or Cdc42) for 48 h 
and subsequently infected with GFP-labeled L. pneumophila wild-type or a ΔicmT mutant strain. Graph (A) 
depicts the GFP fluorescence measured at different time points post-infection (1, 20, 24 and 48 h). 
D. discoideum amoebae (B) or murine RAW 264.7 macrophages (C) were infected with the same strains 
as mentioned in (A) and treated with LAI-1 (1, 5 or 10 µM; 1 h). Uptake efficiency was analyzed by flow 
cytometry (GFP-positive phagocytes). 
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9. LAI-1 partially compensates the lack of LqsA for cell migration inhibition  
Directed and random migration of free-living amoebae as well as mammalian cells were 
inhibited by L. pneumophila or LAI-1 (section A.1. and B.1.). Previous results showed that no 
inhibition of directed migration was observed following infection with the bacterial mutant strain 
lacking the autoinducer synthase LqsA which no longer produces LAI-1. However, it was not 
known whether LAI-1 would compensate for the lack of LqsA during random cell migration. To 
this end, confluent layers of A549 epithelial cells were infected (MOI 10, 90 min) with 
L. pneumophila wild-type, ΔicmT or ΔlqsA strains and treated or not with LAI-1 (10 µM, 90 min). 
Cell layers were scratched and images of the positions were taken at time points 0 h and 24 h 
after (Figure 33A). The percentage of scratch closure was 100% for untreated cells as well as for 
cells infected with the ΔicmT or ΔlqsA mutant strains after 24 h. Furthermore and in accordance 
with previous results (B.6.), the inhibition of cell migration caused by the wild-type strain (closure 
below 10%) was reversed by adding LAI-1 (closure 100%). Also, ΔicmT-infected cells did not 
migrate after LAI-1 treatment, as the scratch remained open with a closure of only 10%. Addition 
of LAI-1 to ΔlqsA-infected cells resulted in scratch closure of only approximately 60%            
(Figure 33B). Therefore, LAI-1 partially compensated the lack of LqsA for cell migration inhibition. 
 
 
Figure 33. LAI-1 partially 
compensates the lack of LqsA 
for cell migration inhibition. 
A. Confluent cell layers of A549 
were infected (MOI 10, 90 min) 
with L. pneumophila wild-type, 
ΔicmT or ΔlqsA and treated with 
LAI-1 (10 µM). Cells were then 
scratched with a sterile pipette 
tip and allowed to migrate for 
additional 24 h. Images were 
taken at the time points 0 h and 
24 h using confocal microscopy. 
B. After 24 h, the scratch closure 
was determined using the 
ImageJ software. The data are 
representative of at least three 
independent experiments 
(Student´s t-test; *** p < 0.001). 
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Taken together, LAI-1 partially reversed the lacking effect of L. pneumophila ΔlqsA on random 
migration. 
 
In summary, the first part (section A) of this thesis revealed an Icm/Dot-dependent inhibition of 
phagocyte migration by L. pneumophila, which is antagonized by LegG1, a translocated Ran 
GTPase activator. 
The second part (section B) established new insights into the effect of the bacterial autoinducer 
molecule LAI-1 on host cell migration. Inter-kingdom signaling by the L. pneumophila QS 
compound LAI-1 inhibits directed and random cell migration by involving IQGAP1, Cdc42 and 
GEF9. 
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IV. Discussion 
A. LegG1 antagonizes the inhibition of phagocyte migration 
by L. pneumophila 
L. pneumophila exploits a broad range of host cell processes including cell motility. In this 
work, an Icm/Dot- and dose-dependent inhibition of amoebae and immune cell chemotaxis by 
L. pneumophila was shown (section A.1.). In previous studies, LegG1 was identified as the first 
bacterial activator of the small GTPase Ran and described as a modulator of microtubule 
polymerization and LCV motility 18. Furthermore, the experiments presented in section A.2. 
demonstrated that LegG1 influences host cell migration. In absence of the Ran activator, a hyper-
inhibition of cell chemotaxis was documented using distinct cell types, migration assays and 
chemoattractants. Upon infection with L. pneumophila lacking LegG1, single cell analysis revealed 
that the FMI and the velocity of cells was decreased (section A.3.). The phenotype was 
complemented by providing legG1 on a plasmid. These results suggest that LegG1 is able to 
antagonize the L. pneumophila-dependent inhibition of cell migration and to stimulate motility of 
protozoan and mammalian cells. Moreover, L. pneumophila- and LegG1-dependent modulation 
of random cell migration was observed in epithelial scratch assays. Ran activation by LegG1 
represents a major downstream effect during L. pneumophila infection 18. The results described 
in section A.4. and A.5. proved that the modulation of cell migration by LegG1 is dependent on 
Ran by regulating microtubule polymerization and consequently random as well as directed cell 
migration. While LegG1 is sufficient to stimulate cell motility, other bacterial effector proteins 
might target further signaling cascades (section A.1). These data suggest that L. pneumophila 
triggers conserved eukaryotic components to inhibit cell motility rather than targeting distinct 
signal transduction pathways involved in chemotaxis (Figure 34). 
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Figure 34. LegG1-dependent modulation of immune cell migration. 
L. pneumophila replicates in LCVs and translocates via the T4SS effector proteins which subvert 
numerous host pathways by targeting the ER and multiple GTPases. The bacterial protein LegG1 
activates the GTPase Ran, stabilizes microtubules and promotes cell migration. Ran activation is triggered 
in the nucleus by the GEF RCC1. It is still unclear how the LCV, LegG1 or RanGTP interact with the 
microtubule network in L. pneumophila-infected cells. 
Abbreviations: ER: endoplasmic reticulum; GA: Golgi apparatus; GAP: GTPase activating protein; 
LCV: Legionella-containing vacuole; Ran: Ras-related nuclear protein; RCC1: regulator of chromosome 
condensation 1; T4SS: type IV secretion system. 
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1. L. pneumophila exploits small host GTPases  
LCV formation is governed by the Icm/Dot T4SS which translocates approximately 300 
different effectors into the host cell. These proteins target many host cell processes including the 
regulation of small host GTPases to exploit the secretory or endosomal pathway 53, 155. Previous 
studies described a broad range of small GTPases which are recruited to the LCV membrane. One 
GTPase can be targeted by more than one Icm/Dot-translocated effector protein, e.g., Rab1 
which is one of the regulatory host factors involved in membrane trafficking and protein 
transport from the ER to the Golgi apparatus (GA) 156, 157. The temporal association of Rab1 to the 
cytosolic face of the LCV is regulated by the multifunctional protein SidM (DrrA) and the GAP 
LepB. SidM is only detected during the first 30 min of infection whereas LepB appears and 
remains for several hours. The Icm/Dot substrate SidM has Rab1 GEF as well as AMPylation 
activity essential for the recruitment and maintenance to the LCV 158. In ΔsidM mutant strains, a 
strong decrease in Rab1 on LCVs was observed, suggesting that the GEF and AMPylation 
reactions are necessary to retain the small GTPase. AMP is removed from the GTPase by the 
deAMPylase SidD. LepB is able to inactivate Rab1 by acting as a GAP and promoting GTP 
hydrolysis. The small GTPase is then detached from the LCV by a RabGDI 55, 159, 160.  
In addition, the bacterial effector protein AnkX catalyzes the transfer of a phosphocholine group 
from CDP-choline to a serine/threonine of Rab1 and Rab35. Moreover, Lem3 is able to reverse 
the AnkX-dependent modification of Rabs by acting as a dephosphocholinase 161. Thus, these 
effector proteins interfere with host vesicle trafficking including endocytic and exocytic 
pathways 162, 163.  
Furthermore, recent proteomic analysis of purified intact LCVs from L. pneumophila-infected 
macrophages identified 14 small Rab GTPases (Rab1, Rab2, Rab4, Rab5, Rab6, Rab7, Rab8, Rab10, 
Rab11, Rab14, Rab18, Rab21, Rab31 and Rab32).  Rab5a, Rab14 and Rab21 were described as 
endocytic GTPases restricting multiplication of L. pneumophila and Rab8a, Rab10 and Rab21 as 
secretory GTPases implicated in Golgi-endosomes trafficking and promoting intracellular growth 
of the pathogen. Most of the Rab proteins localizing to the LCV are specifically enriched on 
vacuoles harboring  wild-type L. pneumophila 149. 
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2. LegG1-dependent Ran activation is crucial for cell migration 
Proteomics revealed the presence of the small GTPase Ran together with its effector 
RanBP1 on LCVs. LegG1, unique to the L. pneumophila Philadelphia strain, functions as a bacterial 
Ran activator and accumulates in an Icm/Dot-dependent manner on LCVs. The pleiotropic small 
GTPase Ran is involved in nucleo-cytoplasmic transport as well as in microtubule formation and 
spindle assembly. Ran activation promotes microtubule stabilization, LCV formation and motility 
as well as intracellular replication 18. LegG1 displays amino acid sequence homology to the 
eukaryotic RanGEF RCC1 and contains a C-terminal CAAX domain. This motif is lipidated by host 
prenylation allowing to target bacterial effectors to host membranes 40, 89, 91.  
LegG1-dependent Ran activation was demonstrated to modulate host cell migration through 
microtubule stabilization (section A.4. and A.5.). So far, further impacts of LegG1 on cell 
migration can not be ruled out, although additional experiments could analyze the effects of 
LegG1 on the actin cytoskeleton and Rho GTPases. Over 20 Rho GTPases have been identified in 
humans targeting protein kinases and actin binding proteins involved in the assembly of F-actin. 
Rho GTPases, present in the lamellipodial region of a cell, promote protusive events and 
motility 164.  
It is also unknown, where  the putative Ran receptor is localized on LCVs. LegG1 is located on the 
cytosolic face of the vacuole and colocalizes with the GA without disrupting it. A spatio-temporal 
regulation of Ran by LegG1 can be in cis or in trans (in a distance from the LCV). Furthermore, 
Ran activity was still present in cells infected with the ΔlegG1 mutant strain, suggesting that Ran 
activation occurs through other eukaryotic GEFs or bacterial effector proteins 18. Besides RCC1, 
the cytoplasmic RanBP10 was described as a eukaryotic microtubule modulator which binds to 
Ran and 1-tubulin and thus might represent a scaffold protein linking Ran activation and 
microtubules 165.  
Two other possible bacterial candidates involved in Ran activation are PpgA (Lpg2224) and LegG2 
(Lpg0276). PpgA, predicted to possess RCC1 domains, shares 16% identity and 25% similarity with 
LegG1 90. Furthermore, LegG2 is possibly able to exchange GDP to GTP 89. However, at this point, 
no LegG2-effect on cell migration, LCV localization or intracellular replication was observed.  
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Investigation of a legG2 mutant strain in combination with siRNA against several RasGTPases 
(Rho, IQGAP1, Ran, Arf, Rab) might lead to new insights and establish a link between LegG2 and a 
host GTPase. 
Ran activation by LegG1 might also be reverted by a hypothetical bacterial Ran GAP. Analogous 
processes were described for Rab1 (SidM/LepB as GEF/GAP, SidM/SidD as AMPylase/deAMPylase 
or AnkX/Lem3 as phosphocholinase/dephosphocholinase) 159, 163. Furthermore, LegG1 might be 
degraded to modulate its activity. For instance, the Icm/Dot substrate SidH is polyubiquitinylated 
by the ubiquitin ligase LubX, thus triggering proteolysis by the proteasome 166. 
Microtubule polymerization and polarization represent key processes in cell migration. Their 
function is mediated by microtubule-associated motors like kinesin, dynein and transport 
vesicles. Intrinsic dynamics are controlled by microtubule associated proteins (MAPs) 62. The 
underlying mechanism for Ran GTPase in the positive regulation of microtubules is still unknown. 
Moreover, it remains unclear how the LCV is interacting with microtubules or how the movement 
is established and maintained. Numerous putative scaffold proteins, like RanBP10 might be 
implicated to link the bacterial vacuole with the microtubule cytoskeleton.  
The benefit for L. pneumophila from the LegG1-dependent promotion of cell migration is 
uncertain. One hypothesis is that the effector protein counteracts Icm/Dot-translocated 
L. pneumophila effector proteins which destabilize microtubules. A large number of essential 
pathways including phagocytosis, vesicle trafficking, cytokinesis and migration might be impaired 
by these effectors. In such a way, LegG1 may dampen or revert a deleterious impact of other 
effectors on the host cytoskeleton. Besides, uncontrolled host movement might impede the 
survival and replication of the bacteria by enhancing energy expenditure necessary for increased 
migration. Thus, pathogens might benefit from specifically targeting membrane and vesicle 
trafficking or cell migration and tip the balance in their favors. 
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B. Inter-kingdom signaling by the Legionella quorum sensing 
molecule LAI-1 
The experiments presented in the second part of this thesis (section B.) demonstrated 
that the autoinducer molecule LAI-1 of L. pneumophila modulates host cell motility. A dose-
dependent inhibition of directed migration by racemic LAI-1 using the chemotactic under-
agarose assay was observed. Furthermore, a pronounced inhibition was documented after 
addition of the (R)-form of LAI-1 (section B.1.). Single cell tracking (section B.2. and B.6.) revealed 
that the FMI but not the velocity was affected by LAI-1. The addition of the autoinducer molecule 
caused microtubule depolymerization and actin destabilization (section B.2.). LAI-1-triggered 
inhibition of directed and random migration was found to be dependent on IQGAP1 and Cdc42 
(section B.3.). Indeed, IQGAP1, which is upstream of Cdc42 (section B.5.), relocalized from the 
cytoplasm to the cell cortex. Furthermore, an GEF9-dependent inactivation of Cdc42 was 
observed after LAI-1 treatment (section B.3. and B.4.). Finally, LAI-1 reversed the inhibition of 
migration caused by L. pneumophila infection (section B.6.) and the absence of Cdc42 triggered a 
pronounced inhibition of cell motility by L. pneumophila (section B.7.). Collectively, these results 
suggest that LAI-1 is a potent agent of inter-kingdom signaling, which affects host cell motility 
(Figure 35). 
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Figure 35. IQGAP1- and Cdc42-dependent modulation of cell migration by LAI-1. 
LAI-1 (directly or indirectly) inhibits the activation of the Cdc42-specific GEF9, which in turn obstructs the 
interaction between IQGAP1 and Cdc42. LAI-1 causes a cellular relocalization of IQGAP1 and might 
affect its stability. The addition of LAI-1 interferes with host cell migration by destabilizing the microtubule 
and actin cytoskeleton 
206
. 
Abbreviations: Cdc42: cell division control protein 42; GAP: GTPase-activating protein; GEF: guanine 
nucleotide exchange factor; IQGAP1: Ras GTPase-activating-like protein. 
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1. LAI-1-dependent gene regulation in D. discoideum  
Analysis of cDNA microarrays revealed transcriptional changes of D. discoideum genes in 
response to the L. pneumophila signaling molecule LAI-1. The transcriptome study showed that 
LAI-1 up- or down-regulates 115 and 144 genes, respectively, to an extent of at least 1.5 fold. 
This number of genes represents approximately 5% of the 5400 genes on the array. 74 up- and 
113 down-regulated genes could be functionally categorized based on the yeast classification 
scheme which was adapted for Dictyostelium 167. Genes involved in vesicle trafficking and signal 
transduction were mostly up-regulated. By contrast, genes implicated in translation, cell 
proliferation and movement were down-regulated. These results are in agreement with the 
notion that LAI-1 directly or indirectly inhibits cell movement. 
On a single gene level, the observation was made that several genes of the ubiquitin proteasome 
system, the „core” autophagy genes atg8 and atg16 as well as the autophagy adaptor 
sequestosome-1, were up-regulated. In addition, gene expression of three members of the ABC 
transporter G family, a gene named iliA (induced after Legionella infection) and the gene 
DDB_G0274423 which encodes a Src homology 3 (SH3) domain-containing protein, was 
increased. The latter gene is homologous to CD2AP, a scaffold protein modulating actin dynamics 
and cell migration 168. However, no difference in migration was observed in A549 cells depleted 
for CD2AP and treated with LAI-1. Therefore, the LAI-1-dependent inhibition of random cell 
migration apparently does not require the SH3-domain protein CD2AP. Moreover, down-
regulated genes included the aldehyde reductase arlA and arlE as well as rliA (repressed after 
Legionella infection) encoding a putative 12 transmembrane protein of the major facilitator 
family. Thus, the transcriptome analysis revealed that synthetic LAI-1 in the micromolar 
concentration range indeed regulates the expression of a number of eukaryotic genes involved in 
processes like protein homeostasis, vesicle trafficking and cell migration 206. 
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2. Potential LAI-1 receptors and transporters 
This section describes potential interaction partners for LAI-1 including G protein-coupled 
receptors, outer membrane vesicles, nuclear receptors or GTPases. The possible signaling 
pathways are summarized in Figure 36. 
 
a. G protein-coupled receptors 
G protein-coupled receptors (GPCRs) are seven transmembrane proteins and form the 
largest group of membrane receptors. The binding of an agonist, orthosterically or allosterically, 
causes a conformational change and an exchange of GDP to GTP 169. This leads to the dissociation 
of the G protein into G and G. Thus, GPCRs function as ligand-regulated GEFs for 
heterodimeric G proteins and are implicated in canonical (G protein mediated) or non-canonical 
(-arrestin-dependent) signaling pathways 170, 171.  
The GPCR signaling network is implicated in cell chemotaxis by sensing external stimuli and 
generation of mechanical forces. Small peptides called chemokines are recognized and trigger 
directed cell migration. The implication of the GPCR machinery is well described in both humans 
and D. discoideum cells, since the cAMP pathway is essential and ubiquitous in cell 
communication 172.  Upon extracellular stimulation, cAMP is produced from ATP by adenylate 
cyclases. The cascade is a GPCR-triggered signaling pathway implicated in various cell processes. 
Following the dissociation of the G proteins, the Ras GTPase is activated which in turn stimulates 
the enzyme PI3K. Those kinases then catalyze the phosphorylation of PIP2 into PIP3. Their 
pleckstrin homology (PH) domains interact with multiple downstream proteins such as 
GEFs/GAPs, signaling adaptors, tyrosine kinases and serine/threonine kinases. This can lead to 
the regulation of numerous pathways including migration and chemotaxis, where neutrophils are 
the first immune cells recruited during infection, known to track and eliminate bacteria 173. 
GPCRs include neutrophil and CXC chemokine receptors 174. CXCR1, CXCR2, CCR1 or CCR2 
represent receptors possibly implicated in LAI-1 signaling which can be easily investigated using 
RNA interference.  
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So far, only the involvement of CXCR4, important in cell migration in cancer 175, was tested. A 
random migration assay using A549 epithelial cells showed no differences in the effect of LAI-1 
after CXCR4 depletion 206. 
Interestingly, oxylipins, involved in QS of Aspergillus spp, induce the cAMP pathway through 
binding to GPCRs called GprC and GprD 176. Furthermore, a putative GCPR could be confirmed by 
analyzing the downstream cascade including Ras and PIP3 activation levels. A D. discoideum 
strain producing PHCrac-GFP represents a promising tool, since amoebae and human leukocytes 
exhibit similar chemotactic behaviors.  
A further aspect of GPCRs is their ability to be internalized and redistributed into            
endosomes 177, 178. Those membrane-bound compartments represent dynamic sites for GPCR-G 
protein activation. Additionally, three main GPCR sorting machineries are induced in endosomes. 
First, the ubiquitin endosome sorting complex required for transport (ESCRT), found in yeast and 
mammals, which is responsible for re-transport and remodeling of the plasma membrane 179, 180. 
Second, the GPCR-associated sorting proteins (GASP) machinery, which reduces the motility of 
the receptors and targets them to the lysosomal pathway for degradation 181, 182. Third, the actin 
sorting nexin 27 retromer tubule (ASRT) system, which recognizes GPCRs via their C-terminal post 
synaptic density protein (PDZ/PSD) domain and contributes to the selective transport of the 
endosomes to the plasma membrane (recycling) or the GA (retrograde transport).  
Since LAI-1 is a small hydrophobic molecule, one hypothesis is that the autoinducer molecule 
directly diffuses through the plasma membrane and binds one of the GPCRs in the endosome. 
Subsequently, LAI-1 may be relocalized in the cell and interacts with the ER or the GA and 
probably interferes with L. pneumophila infection (section B.6.). Studies showed that the 
autoinducer molecule 3OC12-HSL of P. aeruginosa has an impact on bacterial cell-cell signaling 
and host cell responses. The QS compound possesses immune-modulatory properties and 
mobilizes intracellular calcium from the ER which is associated with induction of apoptosis 132. 
These findings suggest the existence of more than one receptor for 3OC12-HSL, a concept which 
cannot be ruled out for LAI-1. The QS molecule of P. aeruginosa influences the migration pattern 
of primary neutrophils by affecting calcium signaling and actin remodeling 102.  
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QS molecules like LAI-1 might also interact with calcium-sensing receptors and cause an 
activation of the phospholipase C (PLC) pathway, which influences the cAMP cascade and cleaves 
numerous phospholipids 183.  
 
b. Outer membrane vesicles 
L. pneumophila is able to release outer membrane vesicles (OMVs) to export proteins, 
lipids and small molecules. OMVs are spherical bilayer structures with a diameter of 100-200 nm 
and contain phospholipids, LPS and outer membrane proteins. OMVs are produced extra- and 
intracellularly during multiple growth phases 184 and are implicated in various processes such as 
biofilm formation and nutrient acquisition 185. This mode of contact-free cell communication 
allows the shedding of many virulence-related proteins within the host cell like, e.g., the zinc 
metalloprotease ProA and the membrane-associated peptidyl isomerase Mip. Recently, the 
intrinsic capacity of L. pneumophila OMVs to fuse with eukaryotic membrane systems was 
demonstrated 185. OMVs inhibit the fusion of phagosomes with lysosomes 42 and exhibit 
proteolytic and lipolytic activities 186. OMVs elicit a specific cytokine response in alveolar 
epithelial cells 184; IL-1, IL-6, IL-12, IL-17, CXCL1 and TNF are secreted 187. Furthermore, a TLR-2-
dependent answer via LPS has been described for L. pneumophila, whereas more frequently a 
TLR-4 induced cascade is observed 185. The release of proteins and molecules by OMVs has also 
been described for other bacteria. The QS molecule PQS of P. aeruginosa is delivered via OMVs, 
which allows the coordinatination of group behavior 188. Moreover, the delivery of bacterial 
components was observed in Escherichia coli  and Salmonella enterica inducing the activation of 
dendritic cells and influencing B- and T-cell responses 189, 190.  
Thus, one hypothesis is that the LAI-1 autoinducer molecule of L. pneumophila is delivered and 
released into host cells by OMVs. Isolation of vesicles and testing in different migration assays 
should address this question and lead to new insights. 
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c. Nuclear receptors 
The possible binding of LAI-1 to cell surface receptors does not exclude a putative 
receptor in the cytoplasm or nucleus. The arachidonate metabolite leukotriene B4 (LTB4), which 
can act as a chemoattractant for leukocytes is able to bind the membrane receptor BLT1/BLT2 or 
the nuclear peroxisome proliferator-activated receptor (PPAR) 191, 192. Three isoforms have been 
identified in mammals, PPAR, PPAR/and PPAR, exhibiting different expression levels in 
specific tissues 193. These ligand-activated transcription factors regulate a broad range of genes 
involved in metabolism, development and homeostasis. PPARs can interfere with NFB-driven 
transcription regulation of inflammatory genes 194. Furthermore, the specific implication of PPAR 
has been described in fibrogenesis, inflammation and wound healing, in vitro and in vivo. Recent 
data showed an up-regulation of macrophage-specific PPAR in a model of pulmonary fibrosis 
causing an anti-inflammatory effect 195. Additionally, studies demonstrated that PPAR functions 
as a negative regulator of pro-inflammatory cytokines during Vibrio alginolyticus infection 196.  
The QS molecule 3OC12-HSL of P. aeruginosa acts as an agonist of PPAR/and antagonist of 
PPAR transcriptional activities 197. Interestingly, GPCRs are found on the nuclear membrane and 
activate similar pathways as the cell surface receptors in various cell types 198. The autoinducer 
molecule of L. pneumophila might diffuse through the plasma membrane or is delivered in the 
cytoplasm and targeted to nuclear PPARs for binding and induction of an inflammatory cascade. 
Further analysis of the signaling and activity cascade of PPARs should lead to a better 
understanding of the LAI-1 signaling pathway.  
 
d. Interaction with GTPases 
LAI-1 might also directly interact with IQGAP1, GEF9 or with other upstream proteins. Due 
to its small size and hydrophobicity, the molecule can diffuse through the membrane and interact 
with host factors influencing cell migration. The Vikstrom group suggested that 3OC12-HSL 
produced by P. aeruginosa could colocalize and interact with IQGAP1 triggering cytoskeleton 
components.  
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Yet, in this study, the autoinducer was effective only at very high concentrations (200 μM) and 
further eukaryotic factors comprising the signaling pathway have not been identified 102.  
Data presented in section B. revealed that the L. pneumophila autoinducer LAI-1 inhibits 
chemotactic and random migration of eukaryotic cells in the low micromolar range through a 
signaling pathway including the host factor IQGAP1, Cdc42 and GEF9. In order to determine a 
potential interaction partner, LAI-1-biotin probes might be captured with a streptavidin agarose 
resin in pulldown experiments and analyzed by SDS-PAGE. The protein bands of interest could be 
analyzed by mass spectrometry. This might shed light onto the dramatic impairment of 
microtubule polymerization and actin stability triggered by LAI-1. 
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Figure 36. Potential LAI-1 receptors. 
1. LAI-1 might bind to G protein-coupled proteins (GPCRs) localized on the cell surface, in endosomes or 
in the nucleus. Following binding of the autoinducer molecule to the receptor, the G proteins are divided 
and G activates the GTPase Ras as well as PI3K. PIP3 is produced and the PH (pleckstrin homology) 
domains allow binding to small GTPases, such as Cdc42. which regulate microtubules and actin filaments.  
2. LAI-1 localized in OMVs from L. pneumophila might be delivered to the host cell and released into the 
cytoplasm where it could bypass multiple processes. 
3. LAI-1 might diffuse through the cell membrane and bind to PPAR in the nucleus. An interaction would 
cause an inhibition of the transcription factor B, subsequent impairment in gene expression and 
cytokine production essential for inflammation and migration processes. 
4. LAI-1 diffuses and directly interacts with IQGAP1 or the specific Cdc42 GEF9 resulting in destabilization 
of the microtubule and actin network. 
Abbreviations: Cdc42: cell division control protein 42; ER: endoplasmic reticulum; GA: Golgi apparatus; 
GAP: GTPase activating protein; GEF: guanine nucleotide exchange factor; GPCR: G protein-coupled 
receptor; IQGAP1: Ras GTPase-activating-like protein; LAI-1: Legionella autoinducer 1; 
MTOC: microtubule organization center; NFB: nuclear factor kappa-light-chain-enhancer of activated 
B cells  OMV: outer membrane vesicle; PH: pleckstrin homology; PI3K: phosphoinositide 3-kinase; PIP2: 
phosphatidylinositol (4,5)-bisphosphate; PIP3: phosphatidylinositol (3,4,5)-triphosphate; PPAR: 
peroxisome proliferator-activated receptor; RXR: retinoid X receptor. 
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C. Possible in vivo analysis of inflammatory processes in the 
lung after Legionella infection 
Migration and activation of immune cells are essential during inflammatory processes and 
disease development. Following inhalation of contaminated aerosols, L. pneumophila infects and 
replicates in phagocytic immune cells in the lung.  Alveolar macrophages are killed during the 
infection, whereas dentritic cells and neutrophils activate natural killer cells through the 
production of IL-12 and IL-18. In turn, these cells are responsible for the release of IFN-199. An in 
vivo analysis would give new insights into the chemotactic recruitment of immune cells during 
the lung inflammation. Furthermore, novel strategies and/or improvement of prevention and 
treatment could be established.  
A/J mice, which support intracellular replication of L. pneumophila, would serve as an infection 
model allowing to study the interactions between the bacteria and host cells as well as host 
defense mechanisms 200, 201. A recently described mouse model allows the investigation of 
pulmonary microcirculation in the ventilated mouse lung through intravital microscopy 202. 
Moreover, besides the A/J mice, three other mouse models are available: (i) LysM-eGFP mice 
with neutrophils producing the fluorescent protein GFP; (ii) CX3CR1gfp/+ mice expressing GFP-
labelled monocytes and (iii) the MHC II-GFP model with GFP-producing dendritic cells 203.  
In real-time analysis of arterioles, blood vessels and capillaries, adherent and rolling leukocytes 
can be detected and followed. After an intranasal infection with L. pneumophila, intravital 
microscopy of an infected lung could be established. Following depletion of alveolar 
macrophages, dendritic cells or neutrophils in the A/J mouse, their implication over time could be 
analyzed 204, 205. Furthermore, different L. pneumophila mutant strains and cytokine production 
can be tested.
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VI. Appendix 
A.  Abbreviations 
AHL     acyl-homoserine lactone 
AI     autoinducer 
AYE     ACES yeast extract 
CAI-1     cholera autoinducer 1 
Cam     chloramphenicol 
cAMP     cyclic adenosine 3´, 5´- monophosphate 
Cdc42     cell division control protein 42 
CHD     calponic homology domain 
CYE     charcoal yeast extract 
DOCK     dedication of cytokinesis 
Dot     defective organelle trafficking 
FACS     fluorescence-activated cell sorting 
FCS     fecal calf serum 
FMI     forward migration index 
fMLP     formyl-methyl-leucyl-phenylalanine 
GAP     GTPase-activating protein 
GDI     GDP dissociation inhibitor 
GEF      guanine nucleotide exchange factor 
GPCR     G protein-coupled protein 
GRD     GTPase activating protein related domain 
h     hour 
Icm     intracellular multiplication 
IFN     interferon   
IFNAR     interferon / receptor 
IL     interleukin 
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IPTG     isopropyl 1-thio--D-galactopyranoside 
IQGAP1    Ras GTPase-activating-like protein 
Kan     Kanamycin 
L     liter 
LAI-1     Legionella autoinducer 1 
LCV     Legionella containing vacuole 
LegG1     Legionella eukaryotic gene 1 
LPS     lipopolysaccharide 
Lqs     Legionella quorum sensing 
M     molar 
MAPK     mitogen-activated protein kinase 
min     minute 
MOI     multiplicity of infection 
MTOC     microtubule organization center 
nm     nanometer 
NFB nuclear factor kappa-light-chain-enhancer of activated 
B cells 
OD600     optical density at 600 nm 
OMV     outer membrane vesicle 
PBS     phosphate-buffered saline 
PI     propidium iodide 
PI3K     phophoinositide-3-kinase 
PIP2     phosphatidylinositol (4,5)-bisphosphate 
PIP3     phosphatidylinositol (3,4,5)-triphosphate 
PMN     polymorphonuclear neutrophil 
PPAR     peroxisome proliferator-activated receptor 
QS     quorum sensing 
R     resistant 
Rac1     Ras-related C3 botulinum toxin substrate 1 
  Abbreviations 
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Ran     Ras-related nuclear protein 
RCC1     regulator of chromosome condensation 1 
RCG     Ras GAP C-terminal 
RhoA     Ras homolog gene family member A 
sec     second 
SorC     Sörensen phosphate buffer 
T1SS     type I secretion system 
T2SS     type II secretion system 
T3SS     type III secretion system 
T4SS     type IV secretion system 
T5SS     type V secretion system 
TBS     TRIS buffered saline 
TCS     two-component system 
TLR     Toll-like receptor 
WT     wild-type 
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